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were

investigated in vitro to determine the influence of 17-Bestradiol and progesterone upon viability.

Stage

specific mouse embryos (2-cell, 4-cell, and a-cell) were
cultured for 8 hours in Whitten's Modified Medium
supplemented with the following compounds:

17-B-

estradiol, tamoxifen, nafoxidine, progesterone, and
aminoglutethimide.

Upon completion of the culturing

procedure PIEs were observed for embryonic progression.
Immunocytochemical assay procedures were also performed
upon the stage specific embryos in an attempt to
demonstrate the presence of estrogen and progesterone
receptors within early PIEs.
Resultant viability data showed that 4-cell and 8cell PIEs are estrogen dependent and that endogenous
estrogen production occurs in these PIE.

Estradiol

supplemented 2-cell PIEs were inhibited in a
concentration dependent manner.

Tamoxifen and nafoxidine

both were demonstrated to be effective antiestrogenic
ii

agents.

No influence of progesterone was shown to exist.

Viability studies demonstrated the lack of endogenous
steroid production influence in 2-cell and 4-cell PIEs,
but a dependence upon endogenous ster.oid synthesis was
shown within a-cell PIEs.

Immunocytochemical studies did

not demonstrate the presence of either estrogen or
progesterone receptors within 2-cell, 4-cell, or a-cell
PIEs.

However, receptor studies were deemed inconclusive

due to the unknown influence of the zona pellucida.
Evidence obtained sup.ports the concept of embryonic
genome initiation at the 2-cell state and endogenous
steroid synthesis at the a-cell PIE stage, but this
initiation was not demonstrated
or progesterone receptors.
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CHAPTER I

INTRODUCTION

The formation of a viable mammalian organism begins
at the time of fertilization.

The early stages from

fertiiization through the time of implantation, ·contain
mysteries that have eluded many researchers concerning
these preimplantation embryos (PIEs).

The unraveling of

those· mysteries was hindered, however, until.the late
1950's due to the lack of biotechnical abilities (Slack,
1983).

Initial difficulties in mammalian embryological

studies centered around the difficulties of 9bserving
viviparous mammalian embryos.

In order to study the

development.of these embryos researchers first needed to
develop methods to isolate preimplantation embryos.

once

the-PIEs were isolated, the need to design culture
techniques necessary-for embryo survival emerged •
..
Problems concerning the isolation and culturing.of
PIEs involved the development of techniques to improve
the maximum number of embryos produced by the organism as
:well.as c9ntrolling the embryos-through in vitro
culturing, to al-low uniformity in development (Gates,
19-71) ·•

Also·, the methodology of: handling the live

embryos in a manner-in which was not-detrimental to the
1
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embryo had to be addressed (Bedford, 1971).

The problems

in producing acceptable PIE yields were centered on the
methodology of inducing superovulation (Edwards and_
Gates, 1959; Gates, 1971).

The techniques of in vitro

culturing have evolved ~rom a simple media, designed in
1949 by Hammonds, to the more productive mediums that are
known today.

The evolution o_f a new generation of

laboratory·equipment, like micropipetors and the newer
designs of microscopes, since the early beginnings of
embryo research when a variety of crude micromanipulating
tools were used, has also assisted in solving the
problems of culturing and handiing encountered in the
outset.
The more recent advances in cellular and molecular
biological techniques have_ made-it-possible for
_experimentat~on on small volumes thro~gh methods like
electrophoresis and radioimmunoassay (RIAs).

Such

<'

:methodology has'.~llowed re~earchers the ability to
discover the presence of specific proteins·, the amount of

RNA synthesis occurring and the utilization of materials
to produce the protein products (Bolton, et al., 1984;
Howlett and Bolton, 1985).

The information gathered

using these techniques has given today's researchers a
·basis for understanding the early developing embryo's
activities.

3

Isolation

of

PIEs

To maximize PIE yield in mice, researchers had to
resolve the problems associated with concentration and
timing of gonadotropin injections, the strain and age of
the mice, and the length of the photoperiod.

The problem

of obtaining a large number of viable embryos was solved
through methods inducing superovulation.

Fowler and

Edwards (1957) induced superovulation in mice following
intraperitoneal (IP) injection of two gonadotr?pins.
The· first gonadotropin was pregnant mare's serum
gonadotropin (PMSG) followed by a second injection
containing human chorionic gonadotropin (hCG).

Since

that.time, most superovulation techniques' utilized by
'

.

researchers'followed the same basic protocol but with
varying doses of the gonadotropins ranging from 2 to 10
international units (IU). This technique was commonly
used since gonadotropin injections induced _superovulation
(Edwards and Gates, 1959) and mice produced about three
times more ova than through spontaneous ovulation (Gates,
1971).
Through experimentation with varying times between
injections, it was found that 44 to 48 hours would permit
an accurate regulation of the ovulation time (Figure 1).
This control would then allow for the collection of PIEs
during specific stages of development according to.the

4

time elapsed post-hCG injectio~ (Edwards and Gates,
1959).

The time needed to elapse before the development

of 2-cell PIEs was found to be 45 hours post-hCG
(Brinster, 1965a), 4-cell PIEs were found to develop 54
hours·· post-hCG "(Brinster, 1967), and 8-cell PIEs were
present 64 hours post-hCG i?}je~tion (Warner and
Tollefson, 1978) (Figure 1).
Besides the use of gona_dotropins and _the . timing .
between the administrations, it was found that the type·
of mouse strain used was also important.

This

observation was based on the fact that different strains
of mice produced different numbers of ova when stimulated
(McLaren, 1967).

It was also known that a more vigorous

reproductive capacity, like that found in outbred mouse
strains, produced more viable ova than those that are
less vigorous, like the inbred strains (Gates and Runner,
1957).

Alo~g with this, prepuberal mice (about 3 weeks

old) were found to produce the highest.yield of ova
(Gates, 1971).
Another factor; the photoperiod,· influences the
yield of PIEs.

Whitten and Dagg (1961) determined the

maximum yield o·f embryos typically involved a light
period between 12 and 14 hours.

_This photoperiod was

also found to be required to accurately time ovulatio_n
events (Gates, 1971). · Since lueteinizing hormon~ (LH) is
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Flgure 1, Time intervals and.considerations for hormone
induced.silperovulation and·PIE. capture.
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typically released in a surge that correlates with the
daily light/dark photoperiod.

Further research into the

action of .LH has also shown that the time between the
peak LH release and ovulation is about 9 hours.
Therefore, the timing of mature Graafian follicle
ovulation is.controlled by endogenous LH stimulation
(Schultz, 1986).
PMSG is a gonadotropin that contains follicle
stimulating hormone (FSH) activity.

Thus PMSG will

induce pre-ovulatory maturation of ovar_ian follicles and
assure the development of mature Graafian follicles
(Schultz, 1986).

The release of LH by mice following·

treatment with PMSG was found to occur 11 to 16 hours
after the second midpoint•of the dark period that is
about 47 to 52 hours post-PMSG injection as diagramed in
figure 1 (Gates, 1969). . ," ·
The other gonaqotropin_ ~CG is an·ovuiatory·hormone
that has LH-like actiyity.

Ovulation through the use of

such an exogenous LH occurs 12 hours following the
addition
of the hCG
(Edwards and Gates,
.
.
. 1969)°.
Therefore, because the natural release of LH stimulates
.ovulation 9 hours after its release pe_ak and exogenous LH
stimulates ovulation 12 hours after its adminis~ration,
the exogenous LH is administered, three hours prior to the
expected endogenous LH peak release (Gates, 1971).

7

Therefore, the administration of hCG should be performed
45 hours following PMSG injection to regulate ovulation
(Figure 1) (Fowler and Edwards, 1957; Ken_dall, 1979).

Emi,ryo Development
The formation and development of the mammalian
embryo from the zygote stage ~o the blastocyst is a
process unique in comparison to other tissue types.
Although multiple cleavage .divisions
occur from. the
'
I

zygote to the blastocysts, there is no increased mass
during the entire· process.

The initial embryonic

division usually occurs 24 hours following fertilization.
sU:bsequent divisions then occur in intervals of about 12
hours.

Until approximately 60 hours post-fertilization,

when the embryo is at the a-cell stage, the PIE undergoes
the process of compaction into a spherical shape (Johnson
and Maro, 1986).
The process of compaction involves the blastomeres
flattening against each other and allowing· for the
maximum amount of contact between cells.

The

establishment of tight junctions, to fix the.blastomere
positions and prevent movement, and gap junctions, to
allow for intercellular communications, also occur at
this time (Magnuson, et al., 1977).

The specific

molecular events involved in this process have been shown

8

to depend upon sterol synthesis, the glycosylation of
_membrane proteins, and the organization of a
microfilament network (Brachet and Alexadre, 1986).
Compaction continues until the 32-cell stage when a
blastocoel first appears (Slack, 1983).
Compaction has also been found to be a ca2+ dependent
action (Slack, 1983, Yamamura and Spindle, 1988). As
compaction proceeds, each blastomere changes from the
transient polarity seen in 2-cell and 4-cell PIEs
(Ziomek, 1987) to a radially polarized pattern (Schultz,
1986).

The significance of the embryc;:mic polarity is not

completely understood but it may function to prevent the
loss of the paternal genetic information at the time of
fertilization of the-egg and may play a role in the
changes within the membrane of the 2-cell and 4-cell PIE
blastomeres.

The permanent polarity that is established

in the a-cell stage is believed to provide the foundation
for the development of the two cell lineages leading to
the trophectoderm and the inner cell mass of the
blastocyst (Ziomek,. 1987).

Evidence ·has also shown that

the differentiation of these two cell lines can be due to
the different environmental conditions the blastomeres
are exposed to according to their orientation within the
blastocyst (Tarkowski and Wrobleweska, 1967).

9

Preimplantation culturing

The initial problem for embryo development was the
evolution of a suitable in vitro culture technique
· {Biggers, et al., 1971).

The first report of in vitro

cultures of mouse embryos was made by Hammond (1949).

He

used a culture medium of physiological saline,
supplemented with hen egg whites and yolk.

Hammond

stated that the successful culture of mice embryos
depends upon the age of the embryos.
.

.

His attempts to

culture 2-cell embryos failed, but he successfully
cultured a-celled PIEs to blastocyst.
Whitten (1956a) modified Hammonds media by
substituting Krebs-Ringer bicarbonate solution for the
saline to control the pH and adding glucose, penicillin
and streptomycin. Eventually, he stopped using egg yolk.
Whitten also found that crystalline bovine serum albumin
{BSA) was a~ excellent substitution for the egg whites.
.
.
Along with this, he gassed his medium with 5% CO2 in air
to establish a .pH of 7.4 {Table 1).

With.these changes

Whitten was able to·culture a-celled mouse PIEs to the
blastocyst stage with an increase in viability over
Hammonds media.
Until 1957 no researcher·was able to culture 2-cell
and 4"'.'celled PIEs (Whitten, 1956a) • ,Whitten changed this
fact, however, by modifying his own media.

He altered
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the Krebs-Ringer bicarbonate solution by repla_cing
calcium chloride with calcium lactate.

With this change

he was able to culture 2-celled PIEs to the blastocyst
stage (1957a) (Table 1).
Efforts to develop an enhanced Whitten's Medium
followed (Biggers, 1987), and in 1965(b) Brinster studied
concentration response curves to discover the optimum
osmolarity required to support embryonic development.
The investigations resulted _in the addition of sodium
lactate, the removal of glucose, and the return to the
original Krebs~Ringer bicarbonate solution containing
calcium chloride that Whitten himself had changed.
Brinster (1965c) also studied the role of metabolic
intermediates of the Embden-Meyerhoff pathway and the
citric acid cycle.

He found that if pyruvate,

'phosphoenol pyruvate, and ·oxaloacetate w~re substituted
for ·lactate, 2-celled PIE development could_.be enhanced.
Brinster (1965b) determined that low concentrations
of ,pyruvate had a joint eff~ct-with lactate to enhance
developmental responses (Table 1).

This medium proved to

enhance the rate·of viability in comparison to Whitten's
original medium.· Therefore, through Brinster's studies
(1965a, b, and c), the improved type of medium was
referred to as Brinster's Medium.

It was then noted that

the availability of pyruvate, lactate, and glucose within

Table 1.

Development of culture media for mouse·preimplantation embryo culture
based on.Krebs-Ringer bicarbonate media.
Whitten

Brinster

BWW

Modified
Whitten

1971

1971

1971

1956

1957

1963

1965

NaCl

X

·X

X

X

X

X

X

X

KCl

X

X

X

X

X

X

X

X

KH2P04

X

:ic .

X

X

X

X

X

X

CaC12

X

X

X

X

MgS04

X

X

X

X

x.

X

X

X

X

X

Ca Lactate

X
X

Na Lactate

X

Na Pyi:uvate
NaHC02

1971·

Whitten

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

·x

X

BSA

X

X

X

X

X

X

X

X

Penicillin

X

X

X

X

X

X

X

X

Streptomycin

X

X

X

X

X

X

X

X

Glucose

EDTA

X

X

.........

12
the media was advantageous to the embryo's development
(Biggers and Brinster, 1965).

This development led to

the formation of various modifications-of Brinster's
Medium into newer forms like a modified Brinster's Medium
(Brinster, 1971), a new. Whitten's Medium (Whitten, 1971)·
and BWW Medium (Biggers, et al., 1971) (Table 1).
Another problem, 'besides_ the development of a
suitable media to culture 2-cell PIEs through blastocyst,
was that of a

11

2-cell block phenomenon." ·This event was

characterized by -the inability of 1-cell embryos that
have completed the first cleavage division in cultu~e,
producing a 2-cell embryo, to progress to the 4-cell
stage while remaining in culture (Cole and Paul, 1965).
one explanation was presented by Whitten and Biggers
(1968}. They stated that because some mouse strains could
not be cultured, unless 2-cell PIEs were present at the
time of recovery, the block was genetically dependent
upon the strain of mouse used.

In 1977, Abramczuk, et

al., determined that the addition of
ethylenediaminetetraacetic acid (EDTA) to Whitten's new
medium enhances the versatility of the culture medium for
PIE culture and is widely used by many researchers today.
This alteration of Whitten's new medium in now called
'Whitten's Modified Medium (Table 1}.

1.3

Embryonic Genome Initiation

The ultimate source of information controlling all
activities of a cell is the genome.· A study by Howlett
and Bolton (1985) indicates that the embryonic genome is
not expressed until late in the 2-cell stage.

If this is

true the control mechanism of early embryogenesis
involves another factor(s).

Recent advanqes ·in molecular

techniques have aided researchers in understanding-this
mechanism (Epstein, 1975).
· In the formation of the mature oocyte (oogenesis),
the precursor oocytes accumulate macromolecules and
·increases 350-fold in size (Magnuson and Epstein, 1987).
The growth phase of the oocyte ends and is marked by the
termination of RNA synthesis.

The mature oocytes that

are arrested at the second meiotic metaphase (Howlett and
Bolton, 1985) then contain sufficient RNA concentrations
to provide for protein synthesis through the_2-cell stage
.

.

(Chen, et al., 1980; Schultz, 1986; Magnuson and Epstein,.
1987).

The mouse egg has then inherited mRNA, tRNA,

rRNA, and ribo·somal proteins from the maternal ·cell line
to subsist on until the 2-cell stage (Howlett and Bolton,
1985):

The paternal gamete does not donate tangible

amounts of such products to be used. The first evidence
of any embryonic transcription has been found at the
early to mid 2-cell stag~; while no detectable RNA

14
synthesis has been measured in the 1-cell stage.
Therefore, prior to the 2-cell stage, maternal components
are being utilized and are done so at the
post-transcriptional level {Howlett and Bolton, 1985).
Further research into maternal mRNA utilization has
demonstrated that from fertilization to the 2-cell stage,
PIEs lose 70% to 90% of the maternal mRNA.

At this point

in development, however, pro_tein synthesis remains
constant {Brinster, et al., 1976).
Once the 2-cell stage has been reached, additional
RNA must be initiated from the embryonic genome and
continue for the remaining life span of the PIE.

This

information was extracted from experiments performed on
1-cell, 2-cell, and 4-cell PIEs using transcriptional
.inhibitors such as a-amanatin {blocks mRNA synthesis by
binding preferentially to RNA polymerase II) and
actinomycln_D {binds DNA and.blocks the movement of RNA
polymerase preventing RNA synthesis (Alberts, et al.,
1989n.

When 'the PIEs were cultured· in environments

containing these compounds, it was seen that only the
2-cell and 4-cell PIEs demonstrated inhibition of embryo
development while the 1-cell PIE was not affected
(Golbus, et al., 1973; Warner·and Versteegh, 1974).

PIE

genome expression must then replace the influence of. the
maternal mRNA in the synthesis of required protein

15
(Howlett and Bolton, 1985).

In fact, it has been

observed that prior to the second cleavage division a six
to eight fold increase in protein production occurs. This
action has, therefore, been considered a result of the
eml:lryonic genome initiation (Schultz, 1986). ·
A primary factor in the onset of genomic
transcription in mice is the length of time since
fertilization.

This genomic transcription usually

follows a cAMP-mediated· transition within· the cell from a
nonpermissive stat~·to a·permissive state· along with·othe:r addition.al events during the 1-cell stage that are
preparatory events.

This transition most likely involves

a .post-translational
modification of transcription
.
.
factors that are then used to begin the transcriptional
phenomenon in PIEs (Latham, et al., 1992).

steroidal Influences
once suitable methods for the cultivation·,
harvesting, and .culturing of embryos were developed,
researchers began investigating the post-fertilization
stages of development.

They have produced simple media

that provide enough elements to allow for the continued
development and vi-ability ·of PIEs.

These in vitro

methods of embryo maintenance, however, have demonstrated
a lag time in embryo development behind that of in vivo
eml:lryos.

The lag time has been attributed to the absence
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of developmental influencing factors, present normally in
the maternal reproductive tract but absent in the media,
that enhance the early blastomere proliferation
(Spielmann, et al., 1980).
Early embryogenesis, beginning with the 2-cell
stage, is highly dependent on the embryonic genome for
the initiation of cell proliferation and differentiation
(Schultz, 1986).

Several possible methods controlling

the genomic activation are possible, ranging from
post~translational modifications in embryonic
transcription factors (Latham, et al., 1992) to hormonal
influences.

Of these hormonal· influences, steroids have

been the most studied factor thought to be involved in
the developmental regulation.

These steroids appear

necessary for implantation to occur but it is not clear
whether steroid hormones actually affect the embryos
directly or whether their action is on the uterus which
then secretes some substance that can stimulate the
embryo (Warner and Tollefson, 1978).
Early research suggested that the ovary was the sole
source of the steroids, estrogen and progesterone,
-necessary for the control of preimplantation as well as
the-implantation of the blastocyst (Dickmann, et al.,
1975).

-In 1973, however, research performed by Perry, et

al., on pig blastocysts contradicted that theory.

The
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investigation presented radioimmunoassay (RIA) evidence
that a pig blastocyst of 14 days post-coitus had
enzymatic activities that are similar to enzymes used to
produce the steroids estrone and 17-S~estradiol.

Because

pig implantation occurs_ 18 days post-coitum, this
evidence was the first to support biological activity in
steroid synthesis by the mammalian PIE.

Succeeding years

produced more evidence that the PIE has the capability to
produce steroids. There is even evidence that ~n rats,
hamsters,-and mice the PIE is an additional source of
steroid hormones and that they to, like the ovary,
synthesize steroid hormones (Dickmann and Dey, 1974;
Dickmann, et al., 1975).

Enzymes other than those that

produce estrogens as.products have also been found to
exist in-the PIE, to produce progesterone, testosterone,
and prostaglandins (Shemesh, et al., 1979).
Confirmation of PIE steroidogenesis was through
testing for the presence of specific enzymes responsible
for steroid production.

Since 3-S-HSD

(3-S-hydroxysteroid dehydrogenase) is a key enzyme in the
metabolism of steroid hormones, its presence.in cells is
interpreted as strong evidence for steroidogenesis
(Dickmann, et al., 1975).

The test.was a relatively

simple one in which the PIEs were incubated in a medium
containing DHA (Dehydroepiandrosterone) a precursor to

18

estrogen.

The PIEs were incubated and checked at regular

intervals for changes in blue formazan granule.deposition
and the intensities of deposits were scored to provide
insight into the amount of positive reactivity or enzyme
activity (Dickmann and Dey, 1974).

These studies showed

that steroidogenesis in rabbits, rats, hamsters, and mice
begins at,· or a little before, the·morula stage and stops
at the early postimplantation stages (Dickmann, et al.,
1975).

These studies, however, only involved 1-cell to

2-cell PIEs and PIEs at the 16-cell to 30-cell stage and
older.

Therefore, the-stages of development between the

·2-cell and 16-cell morula are still unknown in relation
to the exact moment steroidogenesis begins.
Other enzymes are also known to be key enzymes for
the steroidogenesis of specific hormones such as the
int~rconversion between estrone and estradiol by
17-B-HSD, but its activity is considered to parallel that
of 3-B-HSD (Dipkmann, et al., 1975).

Based on the

evidence gathered, it was then postulated that the
endogenously p·roduced steroid hormones of the PIE are
critical for the transformation of the morula to
blastocyst, for implantation, and for the metabolic
activities within the PIE (Dickmann and Dey, 1974;
Dickmann, et al., 1975).
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Estrogen and Progesterone

Most studies that focus on hormonal regulation of
the PIE are concerned mainly with either steroid hormone
influence via exogenous hormones (those originating from
sources other than the embryo itself such as the ovary,
oviduct and uterus) (Warner and Tollefson, 1977 and 1978)
or through endogenous hormones (those that originate
through embryonic steroidogenesis) (Dickmann, et al.,.
1976 and 1977; Sengupta, et al., 1977).
appear to exist.

Both sources

It.is also known that, for the

implantation phenomenon to_work, progesterone and
estrogen are required (Dickmann, et al., 1975).
Early experimentation using estrogen showed that the
hormone, when used in high concentrations, caused the
formation of small cytoplasmic protrusions (blebs) on
rabbit PIEs (Daniel, 1964).

These blebs are structured

in such a manner that they lack an organized nucleus and
contain small amounts of chromosomal material.

Their

formation ·is due to the exce$sive subdivisions of the
PIEs rendering the blastomeres unable· to distribute their
nuclear material equally.

The addition of 17-B-estradiol

has also been shown to induce fertilized rabbit ova
cultured in vitro to express cleavage inhibition and
fragmentation (Kirkpatrick, 1971).
Viability studies· performed by DeMoss (1991)
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demonstrated that 17-8-estradiol inhibits 2-cell
progression at lµg/ml concentration, but had no affect on
4-cell and a-cell PIEs.

Also, through the culturing of

PIEs in tamoxifen (an estrogen receptor antagonist) and
estrogen, DeMoss suggested that 4-cell and a-cell PIEs
produce endogenous estrogen that influence the PIE's
embryogenesis.

He based this conclusion on his

observations that exogenous estrogen had no-affect on
protein production and the administration· of an
antiestrogen like tamoxifen inhibits various types of
protein produc~ion.

His data is further supported by a

previous study of Warner and Tollefson (1978) tnat
observed there is no major stimulation or inhibition of
RNA synthesis in a-cell and blastocyst PIEs cultured in
the presence of estradiol.

Their research did not

involve the use of an antiestrogeri, and ~ecause their
evidence did not show mouse PIEs to be hormone sensitive
target tissues, .they proposed the theory that estrogen
could be acting through the promotion of membrane changes
which could affect cleavage and permeability.

Data

showing 17-B-estradiol directly influences the uptake of
amino acids in the- blastocyst (Smith and Smith, 1971)
also seemed to support the latter theory .. The evidence
presented by DeMoss (1_991) supporting a possible
autocrine or intracrine relationship of endogenous
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estrogen upon PIE development seems the more justifiable.
Progesterone has also been reviewed in both Rl'l'A
synthesis and cleavage aspects.

Similar to estrogen it

was found that progesterone has no noticeable affect upon
RNA synthesis (Warner and Tollefson, 1978).

The area of

cleavage results, however, have been contradictory.

In

his early studies, Whitten tested the affects of
progesterone on mouse blastocyst i~ vitro development
(1965b and 1957b).

He was able to demonstrate that low

concentrations·of progesterone are not _inhibitory upon
cleavage divisions but it is concentrations of 4µg/ml.and
above it is.

Kirkpatrick (1971) confirmed Whitten's.

results, but a study performed by Roberlo and Izquierdo
(1976) failed to show the same effects at a concentration
of 4µg/ml.

In rabbit studies, progesterone

concentrations equal to and greater than lOµg/ml
inhibited cleavage up to the blastocyst stage, but the
PIEs would recover from the cleavage block when
transferred to a medium lacking progesterone (Daniel. and
Levy, 1964) •
Kirkpatrick (1971) suggested that progesterone
.interferes with the supply of essenti~l amino acids to
PIEs through the aggregation of_the molecule at the zona
pellucida ca!-lsing the inhibit.ion· of zona herniation.
Everi though progesterone has a negative effect upon PIE
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development in high concentrations, it was shown that low
concentrations were actually essential to a blastocysts
development (El-Bana and Daniel, 1972)~
Since neither estrogen nor progesterone alone affect RNA
synthesis in PIEs, tests using the two in combination
were performed.

This was done to see if both steroids

interact in a synergistic manner.

The results showed

that there·is no major affect of progesterone and
estrogen together on RNA synthesis in blastocy_sts and
a-celled PIEs (Warner and Tollefson, 1978).

Other

experiments were done to see if estrogen offered any
protection from observed progesterone inhibition
(Whitten, 1957b; Kirkpatrick, 1971).

No protection was

observed.

Antiestrogens

Estrogens are hormones known to induce cell
replication through the stimulatio~ of mitogenic growth
..

factors and/or their respe¢tive receptor synthesis.
These mitogens may act in an autocrine or paracrine
manner.

Estrogens and antiestrogens may then modulate

the growth of cells by differentially influencing the_
cellular production of stimulatory and/or inhibitory
growth factors (Jordan and Murphy, 1990).
Non-steroidal antiestrogens are known to prevent·
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estrogen from expressing their effects on many target
tissues (Clark, et al., 1973; Katzenellenbogen, et al.,
1979).

Both agonists and antago_nists of estrogen are

capable of binding to the same receptor site but their
subtle changes in the receptor protein conformation.
determines the substrate/receptor complexes distinct
biological activity (Jordan and Murphy, 1~90).

In the

case of antiestrogens, the antiestrogen/receptor complex
can bind to the estrogen response elements similarly to
the estrogen/receptor complexes, but it does not
stimulate trans~ription.

This type of-action exemplifies

-one of two classes of antiestrogens.

The -first is a

t~iphenylethylene type that.will permit receptor
dimerization and binding to the response element but
prevents the response element from functio-ning because of
a conformational change in the receptor (Jordan and
Murphy, 1990).

The discovery of another high affinity,

saturable binding site.for the triphenylethylene
molecules, called an antiestrogen-binding site, has
received some ·attention but its involvement as a mediator
of estrogen responsiveness is still in dispute (Fanidi,
et al., 1989; Sutherland, .et al., 1980).

The other types·

are considered pure antiestrogens that bind to estrogen
receptors and prevent receptor dimerization and
subsequent binding.to the DNA (Jordan and Murphy, 1990).
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Because standard antiestrogens such as tamoxifen and
nafoxidine prevent the formation of the appropriate
receptor complex to activate the genome, they are often
used in cell cultures as control substances to
demonstrate that a particular event is estrogen regulated
through the estrogen receptor (Jordan and Murphy, 1990).
Tamoxifen ([Z]-2-[4-(1,2-Diphenyl-1-butenyl)
-pheno_xy]-N, N-Dimethylethanamine) is a newer
non-steroidal molecule that has been suggested to be a
potent antiestrogen (Patterson, 1981;. Jordan and Murphy,
1990; DeMoss, 1991).

It is not considered a pure

antiestrogen but it appears to have an appropriate level
of antiestrogenic activity.

It was originally introduced

in an effort to ease the symptoms of advanced breast
cancer where it is known to act as a potent antiestrogen
(Jordan and Murphy, 1990).

The use of tamoxifen has

since sprea~ to other areas of research.
Tamoxifen was commonly found to inhibit
estrogen-stimulated growth when in low circulating levels
by exhibiting target site specific-effects.

Tamoxifen•s·

activity varies, depending upon the cell line it is
influencing, ranging from fully estrogenic to totally
antiestrogenic for the induction of various genes
(Fuller, 1991).

This leads to the speculation that the

antiproliferative actions of tamoxifen could be mediated
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via mechanisms other than the estrogen receptor (Jordan
and Murphy, 1990) ·•

However, tamoxifen has been shown to

bind to the estrogen receptor and activate a
transactivator function (TAF-1) in the NH2-terminal
domain but it does not activate the TAF-2 in the
ligand-binding domain like estrogen.

Therefore, the

differences in tissue and gene activity in the presence
of.tamoxifen may be determined by whether TAF-1·and TAF-2
or just TAF-1 activity 'is required (Fuller, 1991).
Nafoxidine (l-[2-[4-(3,4-Dihydro-6-methoxy-2-phenyl
-1-naphthalenyl)phenoxy]ethyl]pyrrolidine) is another
estrogen antagonist that competes with estrogen ·for
specific binding sites on the same receptor.

In studies

utilizing Jµg/ml of nafoxidine in a medium having
a-celled PIEs, blastocyst formation was inhibited and the
administration of lµg/ml of 17-B-estradiol did not
reverse the effect (Roy, et al., 1981).

An9ther study of

nafoxidine and its effects upon blastocysts, demonstrated.
that 17-B-estradiol reverses the inhibitory effect
(Sengupta, 1982).

Therefore, both tamoxifen and

nafoxidine may have antiestrogenic properties in PIEs,
and may_ de:nionstra~e . 'the estrogen requiri3ments of the PIE .

ilteroidogenesis
Steroid hormones are generally derived from
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cholesterol through a series of structural modifications.
The intact steroid nucleus forms are all synthesized•
through the same initial enzymatic steps.

The synthesis

of these involve cytochrome P-450 enzymes (mixed
oxygenases that catalyze steroid hydroxylation).
The first step of steroid biosynthesis is the rate
limiting step.

This step occurs in the mitochondria of a

cell and involves a cytochrome P-450 side chain cle~vage
enzyme (20, 22-desmolase) that converts ch.olesterol to
pregnenolone;

Once pregnenolone is produced it is

modified by dehydrogenases and hydroxylating enzymes in·
the endoplasmic reticulum and ·mitochondria to form the
final steroid product to be secreted (Ojeda, 1988;
Kaplan, 1988).
The biosynthesis of progesterone, androgens, and
estrogens all have sim;larities.

The primary correlation

being the initial, rate limiting step. converting
cholesterol to· A5 -pregnenolone· using 20, 22-desmolase
(20,22-Des). Pregnenolone.can then be converted ·to
pro.gesterone by "'JB-hydroxys:teroid dehydrogenase ( 3B-HSD) •
Pregnenolone can also be modified by 17-hydroxylase to
.form

17a-hydroxypregnenolone.

These.can then be

modified further to result in androstenedione f.ormation •.
Testosterone can be produced fr9m the androstenedione and
subsequently be transformed by aromatase (Ojeda, 1988;
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Kaplan, 1988), the terminal enzyme of the cytochrome
P-450 complex (Graves and Salhonick, 1979), into
estradiol.

Androstenedione.can also be converted by

aromatase to form estrone which can then be
irtterconverted to estr~diol by 17B-hydroxysteroid
dehydrogenase (17B-HSD) (Ojeda, 1988; Kaplan, 1988).
As was stated earlier, researchers have been able to
find weak concentrations·of 17B-HSD in the PIE as early
as the 2-cell stage and becomes intense at the morula
stage. Also, 3B-HSD activity is known to begin at the
2-cell stage and gradually increases-until the morula
stage then declines slightly.at the blastocyst stage.
Estrogen and progesterone, however, have not been
detected to be synthesized within the PIEs (Kendall,
1979).

Researchers have ~ot even been able to detect the

conversion of pregnenolone to progesterone by RIA
analysis in mouse embryos prior to implantation (Sherman
and Atienza, ·1977).

Therefore, E!ven though the enzymes

necessary for steroidogene_sis are present· in mouse PIEs,
there has not, as of yet, been any concrete evidence that
the PIEs are actively synthesizing steroid hormones
(Kendall, 1979).

Aminoglutethimide
Research on aminoglutethimide (AG) showed that it
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was able to inhibit adrenal steroidogenesis in vivo and

in vitro by reversibly inhibiting their synthesis from
cholesterol (Kowal, 1969).

In tests on adrenal cortex

cells using O.lmg/ml of AG, no adverse affects were seen
on cell growth, viability, glucose metabolism, protein,
RNA, lipid, and cholesterol synthesis (Kowal, 1969). In
other experiments it was found that AG did not inhibit
3B-hydroxysteroid dehydrogenase, 17-hydroxylase,
21-hydroxylase, or 11-hydroxylase which are used to
convert ~ 5-pregnenolone to cortisol.

However, there. was

an increase in the levels of lipids and cholesterol.
-These results suggest that AG blocks the conversion of
cholesterol to ~ 5-pregnenolone·, the initial step in
steroid biosynthesis (Camacho, et al., 1967).
AG has the ability to inhibit the conversion of
cholesterol to pregnenolone (Kowal, 1969; Faglia, et al.,
1971) •·

The. key site of inhibition by AG is the

cytochrome P-450 enzyme that is associated with
cholesterol side chain cleavage (Uzgiris, et al.; 1977).
AG's main inhibitory effect is on the 20,22-desmolase
complex activity and the 20-hydroxylation of cholesterol
side chains (Horky, et al., 1972).

It is able to inhibit·

the cholesterol side chain cleavage by forming a ligand
with the terminal oxidase cytochrome P-450 (Graves and
Salhonick, 1979j.

-This inhibition has been demonstrated
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with in vitro and in vivo

studies in both animals and

humans (Faglia, et al., 1971). It has also been shown
that AG can inhibit the conversion of androstenedione to
estrone through the aromatase enzyme (Graves and
Salhonick, 1979).

_Mechanism of steroid Action Upon a Gene

Generally speaking, steroid hormones enter the
target cells, interact with a receptor, and ultimately
activate or deactivate a portion of the genome.

Free,

disassociated steroid molecules are characteristically
small (mw = 300) hydrophobic molecules that have the
ability to cross the plasma membrane by simple diffusion.
At this point. a hormone_ can bind to a complementary
receptor protein in a tight but reversible manner
(Alberts, et al., 1989).
Recep~or/hormone complexes then bind the DNA often
times in the form of dimers (heterodimers and homodimers)
at a hormone enhancer site (Fuller, 1991)".

The ·location

of binding can.vary from being adjacent to the target
gene to
being located great distances .in either the 3' or
.
5' end (Ptashne, 1986).

The complex, once associated

with the enhancer site, is able to reguiate
transcriptional initiation through a mechanism that is,
to date, still not completely understood (O'Malley and
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Tsai, 1992; Ptashne, 1986).

What is understood is that

many times, hormone/receptor complexes bound to the DNA
at different.
!:lites can· interact in a synergistic manner
•-.o.."!,:•·•~
!.-::' '7::, ·
7_ •

•

to intensify the amount of control (Hecht, et al., 1988).
The hormone/receptor complex may also bind to the
specific DNA promoter site and result in a conformational
change of the chromatin structure resulting in the·
displacement of a nucleosomal structure.

The nucleosomal

structure, when present, masks other transcriptional
binding sites that need to be bound for promotion of. a
gene.

If the.nucleosome is displaced, then the other

transcriptional binding sites are opened up, allowing for
the corresponding transcriptional factors to bind and
control a gene• (Truss, et

al.,

1992).

Steroid Receptors

For any hormone·to act upon~ cell it must do so
through a receptor.

Most steroid receptors are believed.

to be predominantly nuclear in location (Fuller, 1991).
These receptors are protein structures that are quite
specific for the particular ster?id molecule they can
bind.

They do, however, exemplify similarity and

conservation of both function and structure:

Structural

similarities are visible in two of the three main domains
composing the receptors, the DNA binding domain and the

COCH-terminal ligand-binding domain.
The DNA binding domain is the most conserved region
of the two.

In fact, of the 66-68 amino acids present,

18 are invariant across all animal species.

The

importance of this centrally located domain belongs to a
zinc finger _structure that is involved in the attachment
of the receptor to the DNA at a specific enhancer site or
response element (Fuller, 1991).

Zinc fingers are

sequenc~·specific when binding DNA and are actually
composed of tw'o ·. fingers_, an· N-terminal _and
c~terminal finger.

Together, they determine the target·

site specificity (Schule, et

al.,

1988) •·

The second most highly conserved domain, the COCHterminal ligand-binding domain is responsible for
complexing.with the steroid molecule.

Once the

steroid/receptor complex is formed, a _configurational
change of the receptor occurs exposing.the third domain,
the poorly conserved ~H2-terminal domain.

This final

domain has the primary function of transactivation and
has been termed
the activating region . (Fuller, 1991). _
.
'

The activating region is regarded to interact with
.promoters and cell specific transcription factors to
enhance transcription (Meyer, e_t al. , 19·99) •
Research considering steroid receptors has only just
recently increased in activity.

In fact, it was not
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until 1983 that steroid receptors were shown to bind to
the DNA directly.

Advancement was made possible mainly

due to the development of recombinant DNA technology
allowing for larger concentrations and specificity in
forms of receptors to be readily synthesized (Alberts, et
al., 1989).

Once the techniques for receptor production

were devised, it was shown that steroid receptors fall
into four classes according to sequence.

One class is

called the glucocorticoid response element (GRE).

This

group includes receptors for androgens,
mineralocorticoids, and progesterone.

The other classes

are the estrogen response elements (ERE), thyroid
response elements (TRE), and an orphan receptor class
(named so due to a functional similarity with.other
receptors but there is no.known ligand to activate them)
(Fuller, 1991) •
Other hormone receptors, besides-steroid forms, have
been found to be produced by preimplantation embryos
between the 4-cell and 8-c_ell stages.

One example is the

epidermal growth factor receptor (EGF-R).

Epidermal

growth factor (EGF) is also a product of early
preimplantation stages of mouse embryos.

Besides embryo

derived EGF-Rs, the epithelial cells and stromal cells of"
the maternal uterus also express EGF-Rs.

The embryo

derived EGF most probably has both an autocrine function

33

as well as a paracrine activity.

This information

suggests that embryos norma.lly condition their. own
environment with hormones to prepare the uterus for
implantation while stimulating themselves (Wiley, et al.,
·1992),

Therefore, from this information it is logical to

question if PIEs use other hormones, such as estrogens
and/or progesterone, in a similar ·manner.
It. has also been found that receptors for estrogens
can be isolated from the cytoplasm of rabbit blastocysts
(Bhatt and Bullock, 1974).

A system has recently been_

developed that is commonly used to detect- the presence of
-these receptors (Abbott, 1990 and 1991).

It is an

immunocytochemical assay system that utilizes a sensitive
peroxidase-anti-peroxidase technique allowing for the
visualization of either the estrogen or progesterone
receptors within a specimen.

A monoclonal antibody is

directed specifically against the receptor_ o_f either the
estrogen or progesterone substrate depending on the
desired receptor to be studied.

This test is not similar

to methods-such as radio immunoassays, which are based on
the binding of a substrate to the receptors binding site
thus labeling it, instead.it is based on direct antigenic
recognition of the receptor.

The technique has

successfully been used to determine the presence of
estrogen receptors.in tissues of rabbit uterus, oviduct,
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corpus luteum, mammary gland, pituitary and liver,
cultured breast cancer cells, human breast cancer cells,
and human endometrium protein.

The primary use today

involves the measurement of estrogen and progesterone
receptors within tumor tissues such as breast cancer
tissue to aid in the determination if the tumor will
respond to some type of hormone treatment.

Possible

limitations of the assay technique is dependent upon.
possible cross-reactivity of the rat·IgG with the tissue
to be studied.

There has been no indication of possible

reactivity with mouse tissue to date.

Another limitation

to this procedure is its inability to demonstrate
receptor presence in concentrations less than 10
femtomoles/mg of protein.

Hypothesis

This s~udy will attempt.to determine the influence
.

.

of exogenously administered 17-B-estradiol and
progesterone
on in vitro cultured preimplantation
.
.
embryos. Specifica~ly this research hypothesizes that
17-B-estradiol and progesterone influence PIE development
by binding to their respective receptors within 2-cell,
4-cell, and a-cell preimplantation embryos.

This study

will also attempt to verify the· antiestrogenic properties
of tamoxifen and nafoxidine, and determine if there is
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steroid synthesis by the preimplantation embryos that
influence the embryo's development through the use of
aminoglutethimide, a steroid synthesis blocker.

Analysis

of 17-B-estradiol and progesterone influence, tamoxifen
and nafoxidine antiestrogenic properties, and steroid
synthesis blockage upon 2-cell, 4-cell, and s·-cell
preimplantation embryos will be determined through
comparative viability studies.

Analysis of· estrogen and

progesterone receptor presence in concentrations greater·
than 10 femtomoles/mg of protein will be determined.
through the u~e of an immunocytochemical assay of 2-cell,.
4-cell, and 8-cell preimplantation embryos.
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CHAPTER rr
METHODS AND MATERrALS

Materials Used

Preimplantation embryos (PIEs) were recovered from
hormone-stimulated female mice of the ICR crossbred
strain (Harlan Sprague Dawley, Inc.) that were 5-12 _weeks·
of age.

All mice were maintained under·a constant

photoperiod of 14 hours light and 10 hours dark.
dark period occurred between 9:00 PM and 7:00 AM.

The
Mice·

were feed Purina Mouse Chow (Ralston Purina Company) and
water ad libitum.

A maximum of 4 mice were placed in a

cage and kept in the Lappin Hall Animal Facility.
Estrous cycle was initiated by the injection of Pregnant
Mares' Serum Gonadotropin (PMSG, Sigma Chemical Co.) and
superovulation was induce~ through an injection of huma~
chorionic · gonadotropi_n · (hCG, Sigma Chemical Co.) •
Recovery and culture.of PIEs were performed in the
presence of Whitten's Modified Medium.

Incubation

occurred in an incubator chamber allowing an environm.ent
. of 37°C in humid atmosphere of 5% CO2 in air.

All visual

observations were under a stand_ard dissecting ll!icroscope,
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Estrous Initiation

The initiation of the estrous cycle was achieved
through the use of a gonadotropin (Fowler and Edwards,
1957; Gates and Dronkert, 1965).

Pregnant Mare's Serum

Gonadotropin (PMSG) was delivered in doses of 5
international units ( 5 IU) within a 0.05-cc volume via
intraperitoneal injection (Warner and Tollefson, 1978;
DeMoss, 1991) using a 1-cc syringe with a 25 2/3-gauge
needle.

The PMSG injections were performed at 2:00 p.m.

for each group of experimental animals in order to
synchronize all mice estrous cycles to coordinate the
subsequent hCG injections at a time when the highest
number of ova have matured.

Ovulation Initiation

Human chorionic gonadotropin (hCG) was administered
intraperitoneally through injections of 5 IU (Warner and
Tollefson, 1978; DeMoss, 1991), within a 0.05-cc volume
using a 1-cc syringe with a 26 2/3-gauge needle.
Injection of hCG occurred 45 hours post- PMSG injection at
11:00 a.m ..

Insemination

Immediately following hCG injection two females were
placed in a breeding cage along with a proven fertile
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male.

At 14 and 21 hours post-hCG injection each female

was inspected for a vaginal plug (sperm plug) .to verify
successful copulation (Poueymirou and Schultz, 1987).
Two inspection times were chosen in order to procure
verification of all copulatory events and not misjudge
any positive activity due to· the reabsorption or loss of
the sperm-plug.

Negative copulatory females were

observed for 10-21 days to determine that·no mating had
occurred and were again subjected to the hormonal
stimulation via PMSG and hCG and placed with males.Females with sperm plugs were held till the desired PIE
-recovery time was reached and embryo recovery ensued.

Eml>ryo recovery

Preimplantation embryo recovery was performed 45,
54, and 62 hours post-hCG injection to retrieve 2-cell,
4-cel-l, and. a-cell embryos, respectively (~rinster, 19 65
and 1967; Warner and Tollefson, 1978).

Females were

sacrificed via cervical dislocation and the skin-with
hair was removed from the ventral abdominal wall prior to.
oviduct excision to prevent contamination by hair.

An

incision was made mid-ventrally, lengthwise running from
the rib cage down to the external genitalia.

Also, two

lateral incisions along the rib cage were made and the
skin was retracted.using forceps to expose the viscera.
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The ventral abdominal wall was removed by making a
lateral incision just anterior to the hind legs and two
additional incisions running from the lateral cut to the
rib cage along the lateral abdominal wall were made.

The

muscle mass was removed and placed between the forelegs.
Once the viscera was exposed the digestive tract and any
fat deposits were moved from one side to the other to
allow access to the uterine.horns, ovaries, and oviducts.
The removal of the oviducts was executed by cutting
the uterine horns anteriorly to the uterine body using
microdissection scissors.

The uterine horn and oviduct

were lifted up from the abdominal cavity by. using
watchmaker's forceps and the connective tissue was
removed.

The oviduct was then separated from the ovary

by cutting the bursa near the ovary (Schneider, 1970).
The resultant piece of uterine horn and oviduct were
placed in

<1,

deep-welled glass dish containing a small

amount of clean Whitten's Modified Medium (Poueymirou, et
al., 1989; DeMoss, 1991).

Using a standard dissecting micz:oscope, each oviduct
was removed from the·ut~rus following the removal of
connective tissue on the oviduct near the uterotuberal
junction.

The junction was then severed (Weldon, .1971)

and each oviduct was moved to
Modified Medium.

a

clean pool of Whitten's

A 30-gauge needle, attached to a 1-cc
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syringe filled with Whitten's Modified Medium, ·was
inserted into the oviduct.

The oviduct was then flushed

gently in order to force PIEs out of the oviduct and into
the glass dish. Immediately following the flush, all PIEs
were washed twice in clean pools of culture media within
sterile watch glasses. The transfers were conducted
through the use of a micropipetor (Rainin, P-20 Pipetman)
set at 2µ1 units, with a gel loading tip.

·Transfers were

performed to dilute out and_ minimize any.concentrations
of hormones and/or·other materials that may have been
present in the oviduct at the time of flushing.
Transfers also served to remove any cellular debris (eq.
red blood cells) and lipid droplets (Brinster, 1967).
After the second wash, the PIEs were placed in culture
dishes containing fresh Whitten's Modified Medium, and
placed in an 'incubator.

vlability studies
Culture media:

Whitten's Modified Medium was used

in the recovery and culturing processes of mouse PIEs.
This medium was-chosen due to its proven ability to
supply proper environmental and nutritional·needs· of
murine PIEs in order to facilitate the development to the
succeeding stages of embryonic PIE development through
compaction (Abramczuk, et al.; 1977; DeMoss, 1991).

Each
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week fresh Whitten's Modified Medium was prepared in
100ml volumes to insure the least possible contamination,
degradation of components, and unnecessary waste of
media.
Whitten's Modified Medium was prepared in accordance
to the established protocol of Whitten (1971) and DeMoss
(1991). The weights and volumes of all components are
listed in Table 2.

Sodium chloride, potassium chloride,

potassium monophosphate, magnesium sulfate, sodium
bicarbonate,-sodium pyruvate, calcium lactate, glucose, K
penicillin G, and streptomycin sulfate were dissolved in
100ml of distilled water.

Sodium lactate 60% and

ethylenediaminetetraacetic acid (EDTA) were added along
with 1% (w/v) phenol red, which was used as a crude pH
indicator.· Crystalline bovine serum albumin was added
and gently dissolved into the solution, by light to
moderate agitation
other additions.

to

prevent frothing, following all

The medium was gassed with carbon

dioxide until a pH of 6.8 to 7.2 was reached (Brinster,
1965).

The medium was filtered usin~ a disposable filter

apparatus (Nalge 120 Nalgene, Inc.) with a 0.2 micron
filter.

The medium was stored in a covered container and

refrigerated at- 4°C until used.

Prior to the use of media

for culture, portions of medium were transferred to an
incubation chamber and kept at 37°C in a humid

Table 2.

Formulation of Whitten's Modified Medium (Whitten, :1971)
Component

Concentration/100ml

NaCl

514.00 mg

KCl

36.00 mg

KH2P04

16.00 mg

MgS04

*

7Hz0

29.00 mg

NaHC03

190.00 mg

Na Pyruvate

3.50 mg

Ca Lactate

*

5H20

Glucose
K Penicillin G

Streptomycin S04
Distilled H20 .

53.00 mg
100·.00 mg

s.oo

mg

5.00 mg
100.00 ml

6~% Sodium Lactate

0.37 ml

1% Phenol Red

0.10 ml

. 10mM EDTA

1.00 ml

Bovine Serum Albumin

300.00 mg
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environment containing 5% CO2 to prevent any shock'to PIEs
from the radical change in the environmental temperature
and atmosphere.
PXE culturing:

At the time of PIE placement into

media for cu_l ture, 1ml of the medium was placed into. the
center well of an 60 x 15mm style organ tissue culture
dish (Bioquest Falcon Plastics Division).

Protocol

required 3 embryonic stages of PIE development:
2-cell stage (45 hours post-hCG)
hours post-hCG)

1)

2) 4-cel·l st,age (54

3) a-cell stage (64 hours post-hCG).

Groups of ten embryos were used per· culture dish during
·incubations.

PIEs were cultured for 8 and 10 hours in

each of the treatment groups.· Each of the culture groups
were done in two replicas, for a total of 20 embryos per
treatment group.
Treatment groups: All solutions were added to the
1ml !=)'f'Whitten's.Modified Medium and 10 PIEs.
Group

.x: Eth~nol-saline solution (50µ1).

The

control solution was prepared through the addition of
:20µ1 of ·absoiute· ethanol to 1ml of sterile saline
.
'
solution ( o; 9% ·NaCl) tcr make a 1. 4 x 10·2mM solution of
ethanol.
Group XX:

17-S-estradiol (lµg/50µ1).

The

preparation of the .stock 17-S-estradiol solution
(1mg/1ml) was ·performed by dissolving 10mg of
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17-B-estradiol into 10ml of absolute ethanol to make a
3.6mM concentration of 17-B-estradiol (Roy, et al.,1981).
The 1µ.g/50µ.l solution was made by diluting 20µ1 of the
stock solution with sterile saline solution to a fin.al
volume of 1ml.

The resulting solution has a

concentration of 7. 3 x 10·2mM 17-B-estradiol and 4. 2 x
10-1mM ethanol (Roy et al., 1982).

This concentration was

chosen as a result of published reports indicating
treatments of PIEs with this concentration have no
deleterious effects upon development. (Roy, et al., 1982;
Warner and Tollefson, 1977). A 50µ.l aliquot of the
20µ.l/~ml solution was added to the culture dishes for
this treatment g~oup to give a· total addition of 1µ.g of
17..,;B-'estradiol (3.4 x 10-2mM) a:nd 1.4 x 10·2mM ethanol (Roy
et al_., 1982).
Group III:
'

.

'

17-B-estradiol (0.·5µ.g/50µ1).
I

Ten

microliter~ of the stock solution was diluted with
sterile saline solution to a-final volume of 1ml.

A 50µ.l

al_iquot of the 10µ.l/lml solution was added to the culture
dishes for this treatment group to give a total addition
to 0.5µ.g of 17-B-estradiol.
Group IV:

17-B-estradiol (0.25µ.g/50µ.l).

Five

microliters of the stock solution was diluted with
sterile saline solution .to a final volume of 1ml.

The

resulting solution was then a 5µ.1/lml concentration of
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17-B-estradiol.

A 50µ1 aliquot of this solution was then

added to the culture dishes for this treatment group to
give a total of 0.25µg· of_ 17-B-estradiol.
Group V:

Tamoxifen (Jµg/50µ1).

The tamoxifen stock

solution was prepared by dissolving 1mg of tamoxifen in
50µ1 of absolute ethanol and then diluted to 1ml using
sterile saline.

The procedure resulted in a lµg/1µ1

solution of tamoxifen.

For this treatment group Jµl of

the.stock lµg/1µ1 solution of tamoxifen was added to the
1ml of culture medium and 50µ1 of the ethanol-saline.
solution from.Group I was also added.
Group VI:

Tamoxifen (2µg/50µ1).

Medium plus 2µ1 of

the stock tamoxifen solution. along with 50µ1 of the
ethanol-saline solution from Group I.
Group VII:

Tamoxifen (lµg/50µ1).

Medium plus lµl

of the stock tamoxifen solution along wi_th 50µ1 of the
ethanol-saline solution of Group I.
Group VJ:II;

Nafoxidine (Jµg/50µ1).

The nafoxidine .

solution was prepared by dissolving 1mg of nafoxidine.in
50µ1 of absolute ethanol and then diluting to 1ml using
sterile saline. · A Jµl aliquot of the solution was added
directly to the medium along with 50µ1 of ethanol-saline
solution of Group I.
Group IX:

Progesterone (lµg/50µ1).

The

progesterone stock solution (1mg/1ml) was prepared by
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dissolving 10mg of progesterone into 10ml of absolute
ethanol.

To make a lµg/50µ1 solution, 20µ1 of the stock

solution was diluted with sterile saline solution to a
final volume of 1ml.

A 50µ1 aliquot of the lµg/50µ1

stock solution was then added to the medium.
Progesterone (0.5µg/50µ1).

Group x:

A 10µ1 aliquot

of the stock progesterone solution (1mg/1ml) was diluted
to a final volume of 1ml with sterile saline solution.
Fifty microliters of the resulting 10µ1/lml solution was
then added to the medium.
Group XI:

Progesterone (0.25µg/50µl).

A 500µ1

sample of the progesterone solution from Group X
(10µ1/ml) was diluted to 1ml with sterile saline to
produce a 0.25µg/50µ1 solution of progesterone, of which
50µ1 was added to the medium.
Group XII:

(lµg/50µ1).

Tamoxifen (3µg) plus 17-B-estradiol

Three microliters of the tamoxifen stock

solution was added to the medium and incubated for 15
minutes.

Following the given time period 50µ1 of the

20µ1-/lml solution of 17-B-estradiol was introduced into
the medium.

The delayed administration of 17-B-estradiol

. was done to permit tamoxifen sufficiept time to bind the
estrogen receptors·, if present •.
Group XIII:

(lµg/50µ1),

Tamoxifen · (•2µg) plus 17-B-estradiol

Two microliters of the tamoxifen stock
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solution was added to the medium and cultured similarly
to Group XII.
Group XIV:

(lµg/50µ1).

Tamoxifen (lµg) plus ·17~B-estradiol

A lµl aliquot of the tamoxifen stock

solution was added to the medium and cultured similarly
to Group XII.
Group xv:

Nafoxidine (3µg) plus 17-B-estradiol

(lµg/50µ1)" •. A 3µ1 aliqu·ot of nafoxidine stock solution
was added to the medium and incubated for 15 minutes.
Following the given time period 50µ1 of the 20µ1/lml 17B-estradiol solution was introduced to the medium.

The

delayed administration was done to permit nafoxidine
sufficient time to bind the estrogen receptors, if
present.
Group XVI:

Progesterone (lµg/25µ1) plus 17-B-

estradiol (lµg/25µ1).

A 40µ1 volume of the 1mg/1ml stock

progesterone solution was diluted to ·a final volume of
.lml with sterile saline.

Thelµc;J/25µ1 17-B-estradiol

solution was prepare_d similarly to the lµg/25µ1
progesterone solution.. . Both s~lut:ions. were added to the
medium in 25µ1 aliquots at about the same time.
Group XVI:i::

Methanol-saline solution (50µ1).

The

control solution was prepared through the addition of
20µ1 of methanol to 5ml of sterile saline solution.

A

50µ1 volume of the stock solution was the added to the
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medium.
Group ~III:

Aminoglutethimide (l0µg/50µ1).

The

preparation of the stock aminoglutethimide solution
(1mg/5ml) was performed by dissolving 5mg of
aminoglutethimide in 100µ1 of methanol..
then stirred for about 2 hours.

The solution was

Fifty microliters of the

solution was·then added to the medium.
Group XIX:

Aminoglutethimide (lµg/50µ1).

100µ1 of

stock aminoglutethimide solution (1mg/5ml) was diluted to
a final volume of 1ml with sterile saline solution ..
Fifty microliters of th,e resulting lµg/50µ1 solution was
·then added·to the medium.
Aminoglutethimide (0.lµg/50µ1).
100µ1 of
..
the lµg/50µ1 aminoglutethimide solution was diluted to a
Group X~:

final _volume o_f 1ml with sterile saline solution.

Fifty

of the resulting O.lµg/SOµl·~otution 'was theri added to
the medium •.

The culture experiments using 2-cell, 4-cel·l and 8cell PIEs were conducted in collections of 10 embryos
with 2 replicas for each treatment group.

Twenty PIEs

were cultured per_treatment group for each developmental
stage.

'

Immediately following embryo transfer to the

medium within the culture dish and addition of steroids,
steroid antagonists, or aminoglutethimide, the PIEs were
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incubated for 8 hours at 37°C in an atmosphere of 5% CO2
in air.

The PIEs were then examined for viability

following the 8 hour incubation.

Viability was based on

the progression of 2-cell, 4-cell, and a-cell PIEs to 4cell, 8-cell, and morula stages respectively.

PIEs not

progressing or failing to advance during the given
incubation period were considered inhibited in their
development or inviable.
Statistical. significance between PIE treatment
groups was determined thro.ugh the use of the standard
normal z-statistic that was used at p < o.05.

Receptor determination
Collection and Preparation of specimens:

Upon

collection of PIEs (in the same manner as stated
previously) at the 2-cell, 4-cell, or a-cell stage, the
embryos we~e temporarily placed in Whitten's Modified
Medium to allow for pooling of all embryos gathered
without.any detrimental effects upon theni.

Once gathered

and washed twice with new media, one third of the
collected embryos were picked up in a small volume of
media (4µ1) using .a.microliter pipetor (Rainin, P-20
Pipetman).

Cells and media were then gently expelled

onto the surface of a microscope slide pre-treated with a
tissue adhesive (Fisher Biotech ProbeOn Plus microscope
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slides), the three stages tested (2-cell, 4-cell and acell PIEs) were placed on separate sections of the slide
to aid in location of different
stages as. desired and
.
spread gently over a small area, to allow for dispersion
of PIEs in a small area.

The slide was then allowed to

air dry just until the edges began to dry, to give the
PIEs sufficient time to bind to the slide surface.

At

this point the slide was placed into a microscope slide
transfer container filled w_ith 95% ethyl· alcohol (95ml
ethanol plus 5ml H20) to fix the PIEs.

The remaining

embryos not already placed onto a slide were then divided.
in half and placed on individual slides in the same
manner as above to give a total of three slides all
·containing an equal number of PIEs for that embryonic
stage of development.

One served as a negative control,

one for the estrogen receptor determination_, and one for
the progesterone receptor determination.

All slides were

kept in the 95%.ethyl alcohol solution at all times at
room temperature.

At no time were the slides allowed to

dry completely, to prevent desiccation of the PIEs and
any possible loss of receptors.

Slides were then

transported to the Special Procedure Laboratory at· the
University of Louisville Medical and Dental Research
Building ~ithin 24 hours, where the immunocytochemical
staining procedure was performed.

Staining was done
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within 24 hours of PIE collection to prevent any possible
loss of receptors over an extended time period.

Only one

slide was used as a negative control since both the ERICA and PgR-ICA systems used the same methods to produce
a negative control slide.
Fifteen PIES in the 2-cell stage of development were
collected and 5 PIEs per slide.

PIEs in the 4-cell stage

of development were collected and 90 PIEs were used, 30PIEs per slide prepared.

PIEs in the a-cell stage of

development were collected and 18 PIEs were used, 6 PIEs
per slide prepared.
The staining procedure

Immunocytochemical Assay:

began with the placement of slides into a PBS solution
(0.0lM phosphate buffered saline, pH 7.2 to 7.4).

The

slides were removed, a blocking reagent was added to the
slide dropwise to pre:vent any nonspecific binding by the
•

t '

.

'

subsequent antibodies, and the slides were incubated for
15 minutes at.room·temperature in a humidified chamber.
Excess reagent was removed and the primary antibody-of
the estrogen
receptor
was added to· one oCtJ:ie specimens,
,.
.
.
the primary antibody of the progesterone receptor was
. added to another specimen, and the control antibody was
added to the third specimen.

The slides were ~ncubated

for 30 minutes in a humidified chamber at room
temperature.

The slides were then placed in two
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successive PBS baths for 5 minutes.

Excess PBS was

removed and the bridging antibody was added to all slides
and incubated for 30 minutes in a humidified chamber at
.room temperature.

Two successive baths followed using

PBS for 5 minutes each.time.

A peroxidase-anti-

peroxidase (PAP) complex was added to all slides and
incubated for 30 minutes in~ humidified chamber .at room
temperature.

Two more successive PBS baths were

performed for 5 minutes each.

Excess PBS was _removed and

the color development procedure began.
Color development involved the immediate addition of
the chromogen substrate solution to each slide following
'the last PBS bath.

The slides were incubated in the

solution for 6 minutes.

Afterwards, the excess solution

was drained and the slides -were gently ri~sed with
distilled water for 5 minutes.
Counterstaining was performed using methyl green.
During this procequre the slides were placed in the
methyl green solution for ·_5 minutes then removed and
rinsed with gently running tap water an additional 5
minutes.
The slides were then placed in a 95% ethanol
solution for about 2 minutes, to begin the mounting
procedure,-then repeated using fresh solution.

The

slides were transferred to absolute ethanol for about 2
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minutes and repeated with fresh ethanol,

Once removed

from the ethanol solution and placed into two successive,
fresh xylene solutions for 2 minutes each.

Finally a

coverslip was added to each slide with permount.
Positive control slides were also done at the same
time as·the above to insure the reagents and methodology
used were suitable and in working·condition.

These

slides were prepared using tissue from· a tissue sample
containing breast tumor cells known to positi~ely stain
using the procedure.
Determination for·the presence of estrogen and/or
·progesterone receptors was done through the use of a
standard light microscope.

Indication of a reddish-brown

stained nucleus within the PIEs, more than that shown by.
the negative control slide, should suggest receptor
presence.

The lack of a reddish-brown stained nucleus

but instead a green stained nucleus, due to.methyl green
counterstaining, demonstrates the receptors are not
present or are in concentrations less· than 1x10-14M/mg of
protein.

This test is not quantitative but is

qualitative for receptor pre:;;ence and, therefore,
suggests only the presence and not specific
concentrations of the receptors if greater than
1x10-14M/mg of protein.
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CHAPTER I I I

RESULTS

Viability.Data
Two Cell PIEs:

Following ans hour incubation

period, preimplantation embryos for individual treatment
groups were observed·to determine if cleavage or cell
division had occurred during incubation.

Collected data

for the influence of 17-S-_estradiol at varying
concentrations on 2-cell PIE progression are presented in
Table 3.

The control treatment group, Group I (Ethanol-

saline), had an 80% progression to the ensuing 4-cell
stage.

Therefore, addition of 50µ1 of the ethanol-saline

solution to the Whitten's Modified Medium allowed for the
progression of a suitable number of embryos and provided
confirmation for the use of 'ethanol-saline solution
addition as an experimental control in viability
comparisons.
Treatment Group II, PIES incubated in the presence
of lµg 17-S-estradiol, exhibited a progres~ion of 4 PIEs
out of 20 to the 4-cell stage.

This reduction in

progressi,on as compared to tJ:ie experimental control was
found to be significant-at p<0,'05.

Treatment Group III

·' and· IV, 0.5µg and 0.25µg of 17;_8-estradiol, permitted 11

Table 3.

Group

Interaction of 17-B-es.tradiol on the progression of 2-cell mouse
preimplantatiori embryos in vitro culture for 8 hours.
Concentration of.
Drug/Vehicle per ml

Total No. of
Embryos
Cultured

Total No.
Advancing to
4-cell Embryo

% of 2-cell Embryos
Advancing after 8
hours Culture

II

17-B-Estradiol
(lµg)

20

. 4•,b

20

III

17-B-Estradiol
co·. 5µg)

20

11

55

IV

17-B-Estradiol
(0.25µg)

20

14

70

Ethanol-Saline
20
16
Control (50µ1)
•significant at p < 0.05 from control Group I
hsignificant at p ·< o. 05 from· Treatment Groups III and IV
I

80

u,
u,
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and 14 PIEs to progress, respectively.

These values were

not found to be significantly different from the control
group.

However, in comparisons .between the lµg and both

the 0.5µg and 0.25µg 17-B-estradiol treatment groups, it
was found that the lµg group was significantly (p<0.05)
different from Groups III and IV.

Thus, 17-B-estradiol

has an apparent dose response action on the 2-cell PIE
progression.
When 2-cell PIEs were cultured in the presence of
tamoxifen at· Jµg, 2µg, and lµg amounts. (Treatment Groups
V, VI, and VII) all groups.dem9nstrated a 70% progression:
after 8 hours of incubation,. as. shown in table 4.
Culture of 2-cell PIEs in a medium containing Jµg of
nafoxidine, Treatment
Group VIII, exhibited
a ·75%
'
·,
'
progression rate.

All concentrations of tamoxifen

demonstrated no significance from either the control,··
Group I, or Group VIII, the nafoxidine-treated medium.
Likewise, Treatment.Group VIII showed no significance
from the control.
Progesterone was used in Treatment Groups IX, X, and
XI (Table 5)-at concentrations of lµg, 0.5µg, and
- 0.25µg, respectively.

A progression of 75% of the 2-cell

PIEs in Group IX was exhibited.as well as 65% for Group X
and 70% for Group XI.

These values, however, were not

significant from the ethanol-saline control nor between

Table 4.

Interaction of antiestrogenic compounds-on the progression of 2-cell
mouse preimplantation embryos in vitro culture for 8 hours.
Concentration of
Drug/Vehicle per ml

Total No. of
Embryos
Cultured

Total No.
Advancing to
4-cell Embryo

% of 2-cell Embryos
Advancing after 8
ho'!lrs Culture

v-

Tamoxifen (Jµg)

20

14

· 70

VI

Tamoxifen (2µg)

20

14

70

VII

Tamoxifen ( lµg)

20

14

70

VIII

Nafoxidine (Jµg) _

20

15

75

Ethanol-Saline
Control (50µ1)

20

16

80

I

!JI

-.J

Table 5.

Group

Interaction of progesterone on the progression of 2-cell mouse
preimplantation embryos in vitro culture for 8 hour's.·
Concentration of
Drug/Vehicle per ml

Total No. of
Embryos
Cultured

Total No.
Advancing to
4-cell Embryo

%_of 2~cell Embryos
Advancing after 8
hours Culture

IX

Progesterone ( lµg) _

20

15

75 ·

X

Progesterone (0.5µg)

· 20

13

65

XI

·Progesterone .(0.25µg)

20

14

60"

20

16

80_

I

Ethanol-Saline
Control (50µ1)
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each of the progesterone treated groups.
Besides tamoxifen, nafoxidine, and progesterone each
being incubated in Whitten's Modified Medium alone, each
was incubated in the medium along with a lµg allocation
of 17-B-estradiol.

The results are listed in table 6.

When lµg of progesterone was incubated with·the 17-Bestradiol (Group XVI) 45% of the 2-cell PIEs progressed
to the 4-cell stage.

This progression was not

significant when compared tq the control group (Group II)
which was incubated· ·in only lµg of 17-B-estradiol in -the
medium.

When compared to the control Group I, treatment

with ethanol-saline alone, it was found that progesterone
and 17-B-estradiol when combined significantly decreased
cell viability (p<0.05).

Therefore showing no

significant protection by progesterone from estrogen at
the 2-cell stage of development.
The culture of Jµg nafoxidine with 17-B-estradiol
(.Group XV) produced similar numbers as the progesterone,
Treatment Group XVI (Table 6).

Upon culture Of tamoxifen

with 17-B-estradiol _in Groups XII, XII, al)d XIV it was
found that both Jµg (XII) and 2µg (XIII) provided for
35%, while tamoxifen at a ·1µg concentration 'in the
presence of 17-B-estradiol (Group XIV) produced 40% PIE
progres·sion (Table· 6).

None of· these values were

significant at the p<0.05 level when compared to the

Table 6.

Interaction of tamoxifen, progesterone·and nafoxidine while.in the
presence .of a lµg concentration of 17-B-estradiol on the progression
of 2-cell mouse preimplantation embryos
vitro culture for s hours.·

in

Group·

·concentration of
Drug/Vehicle per ml

Total No. of
Embryos
cultured

Total No.
Advancing to
-4-c!a!ll Embryo

% of 2-cell Embryos
Advancing after 8
hours culture

XII

Tanioxifen (3µg) +:
17-B-Estradiol (lµg)

20

7•

35

XIII

Tamoxifen (2µg) +
11,,,s-estradiol (lµg)

20

7•

35

XIV

Tamoxifen (lµg) +
17-8-estradiol (lµg)

20

s•

40

XV

Na'foxidine (3µg) +
17-B-estradiol- ( lµg)

20

XVI·

Progesterone ( lµg) +
17.-B-estradiol ( lµg)

20

9•

45

Ethanol-Saline·
Control (50µ1)

20

16 ·

80

I
II

17-B-Estradiol
20
Control (lµg)
•significant at p < o ..05 from· Treatment Group I

45

20

gi
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control, Group II, consisting of only 1µg of 17-Bestradiol.

No significant difference was noted between

Treatment Groups XII, XIII, ·and XIV, or XVI.

However,

there was still a significant level of inhibition of PIE
progression when compared to PIEs cultured in the·
presence of ethanol~saline alone.
When 2-cell PIEs were cultured in the presence of
varying concentrations of a steroid synthesis blocker,
aminoglutethimide, it was found that lOµg, 1µg, and 0.1µg
concentrations (Groups XVIII, XIX, and XX) allowed for·
75%, 70%, and 85% progression (Table·7).

These values

are not significant from the control group of methanolsaline (Group XVII), which was predetermined to be a
suitable medium for 2-cell PIE progression in-a similar
manner as the control, Group I.

Groups XVIII, XIX, and

XX were also noted as not being significant from each
other.
Pour ce°il PIEs:

Data obtained for 4-cell PIEs

incubated for a hours in specific treatment groups are
presented in tables 8 - 12.

The.control, Treatment Group

I (ethanol-saline solution), provided a 7.0% progression
to the a-cell stage.

This showed that the use of Group I

as a control in 4-,cell PIE progression studies was
possible due to its permissive action allowing for PIE
progression.

Table 7.

Group

Interaction of aminoglutethimide on the progression of 2-cell mouse
preimplantation embryos in vitro culture for 8 hours.
concentration of
Drug/Vehicle per'ml

Total No. of
Embryos
Cultured

Total No.
Advancing to
4-cell Embryo

% of 2-cell Embryos
Advancing after 8
ho.urs Culture

XVIII

Aminoglutethimide
(l0µg)

20

15

75

XIX

Aminoglutethimide
(lµg)

20

14

70

xx

Aminoglutethimide
(0.lµg)

20

17

85

Methanol-Saline
Control (50µ1)

20

16

80

XVII

R3
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Collected data for the influence of 17-B-estradiol
at varying concentrations on 4-cell PIE progression are
presented in table a.

Treatment Group II. (lµg of 17-B-

estradiol) exhibited a progres~ion of 17 PIEs out of 20.
This progression of 85%-to the a~cell stage was found not
to be significant from the control, Group I.
Concentrations of o. 5µg and o.• 25µg 17-B-estradiol both
allowed 16 out of 20 PIEs to progress for an 80%
viability that was .also not significant. 'No significance
was visible between Groups II, III, and IV, the varying
concentrations of 17-B-estradiol.
When 4-cell PIEs were cultured in the presence of
tamoxifen at 3µg; 2µg, and lµg amounts (Groups V, VI, and
VII) :all showed signific13-nce (p<0.05) with_ 20%· (4 of 20),
15% (3 of 20), and 15% (3 of 20) respectively (Table 9).
Treatment Group xv (3µg of 'nafoxidirie) ·allowed only 4 of

a

20 PIEs' to· develop
that was
. -,for. . 20% viability
'
significant (p<0.05) from the control.

The four anti-

estrogenic treatment groups (Groups V, VI, VII, and VIII)
showed no significance between each other.

These results

suggest that tamoxifen and na.foxidine are both inhibitory
to 4-c.ell PIES.
Treatment Groups IX, X, and XI ·(lµg, 0.05µg, and·
0.25µg of progesterone) showed progressions of 14 of
20(70%), 15 of.20 (75%), and 15 of 20 (75%) respectively

Table 8.

Group

Interaction of 17-B-estradiol on the progression of·4-cell mouse
preimplantation embryos in.vitro culture for 8 hours.
Concentration of
Drug/Vehicle per ml

Total No;
Total No. of.
··'Embryos
Advancing to
· a-cell Embryo
Cultured

· % of 4-cell Embryos

Advancing after 8
hours Culture

17-6-Estradiol (lµg)

20

17

85

III

17-B-Estradiol
(0.5µg)

20

16

80

IV

17-B-Estradiol
(0.25µg)

·20

16

80

I

Ethanol-Saline
Control (50µ1)

20

14

70

II

'.

Table 9.

Group

Interaction of antiestrogenic compounds on the progression of 4-cell
mouse preimplantation embryos in vitro culture for 8 hours.
Concentration of
Drug/Vehicle per ml

Total No. of
Embryos
Cultured

Total No.
Advancing to
a-cell Embryo

% of 4-cell Embryos
Advancing after 8
hours Culture

V

Tamoxifen (Jµg)

20

Vl

Tamoxifen (2µg)

.20

3•

15

VII

Tamoxifen (lµg)

20

3•

15

Nafoxidine (3µg)

20

4•

20

14

70

VIII

I

Ethanol-Saline
20
Control (50µ1)
•significant at p < 0.05 from control Group I

20

66

(Table 10).

None of these groups was significant from

either the control, Group I, or each other.
When PIEs were cul tur.ed in the presence of lµg
progesterone and lµg 17-B-estradiol (Group XVI) 75%
advanced to the a-cell stage, which was not significant
from the controls, Groups I and II (Table 11).

Culture

Groups XII, XIII, XIV, and XV all showed significant
(p<0. 05) decr·eases in progression ·compared to Group II.,
and there was a significant decrease in viability from
the ethanol-saline control, Group I (Table 11)..
.
.

.

There

was no significance between Groups XII, XIII, XIV, and
XV.

These result substantiate that nafoxidine and

tamoxifen act in an anti-estrogenic manner at the 4-cell
stage.
Four-Cell PIE progression was also noted not to be
inhibited significantly by aminoglutethimide (Table 12)
at concentrations of l0µg (Group XVIII), lµg· (Group XIX),
and 0.lµg (Group-XX) when compared to the·control, Group
XVII, of a methanol-saline solution.

Eight Cell PIEs:

Tables 13 - 17 contain information

on the progression·of 8-ceil PIEs in the various
treatment groups.

Control Group I (ethanol-saline

treatment) and control.Group XVII (methanol-saline) were
determined to be suitable culture groups to allow for a-

Table 10.

Group

IX

X

XI

I

Interaction of progesterone on the progression of 4-cell mouse
preimplantation embryos in vitro culture for 8 hours.
· Total No. of
Embryos
Cultured

Total No.
Advancing to
8-ceil Embryo

% of 4-cell Embryos

Progester·one ( lµg).

20

14

70

Progesterone (0.5µg)

20

15

75

Progesterone (0.25µg)

20

15

75

Ethanol-Saline
Control (50µ1)

20

14

70

Concentration of
Drug/Vehicle per ml

Advancing after 8
.hours Culture

Table 11.

Group

Interaction of tamoxifen, progesterone and nafoxidine while in the
presence of 17-8-estradiol on the progression of 4-cell mouse
preimplantation embryos in vitro culture for 8 hours.
Concentration of
Drug/Vehicle per ml

Total No. of
Embryos
Cultured

Total No.
Advancing to
a-cell Embryo

% of 4-cell Embryos
Advancing after 8
hours Culture

XII

Tamoxifen (Jµg) +
17-B-Estradiol (lµg)

20.

5•,b

25

XIII

Tamoxifen (2µg) +
17-B-estradiol (lµg)

20

5•,b

25

XIV

Tamoxifen (lµg) +
17-B-estradiol (1µg)

20

6*,b

30

xv

Nafoxidine (Jµg) +
17-B-estradiol (1µg)

20

ga,b

40

XVI

.Progesterone (1µg) +
17-B-estradiol (1µg)_

20

15

75

20

14

70

17

85

I

Ethanol-Saline
Control (50µ1)

17-B~Estradiol
20
Control (1µg)
•significant at p < 0.05 from control Group I
bsignificant at p < o.o5 from control Group II
II

0\
00

Table 12.

Group

Interaction of .aminoglutethimide on the progression of 4-cell mouse
preimplantation embryos in vitro culture for 8 hours.
Concentration of
Drug/Vehicle per ml

:"'Total No.·
Total No. of
Embryos
: Advancing to
Cultured
a-cell Embryo

% of 4-cell Embryos
Advancing after 8
hpurs Culture

XVIII

Aminoglut~thimide
(l0µg)

'20

15

75

XIX

Aminoglutethimide
(lµg)

20

15

75

xx

Aminoglutethimide
(0.lµg)

20

17

85

Methanol-Saline
Control (50µ1)

20

17

85

XVII
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cell PIE progression to the morula stage of development.
Collected data for the influence of 17-B-estradiol
at varying concentrations on a-cell PIE progression to
the morula stage are presented in table 13.

Treatment

Group ,II (lµg of 17-B-estradiol) exhibited a progression
of 16 PIEs out of _20.

This progression of 80% to the

morula stage was found not to be significant from the
control, Groµp I. ,A concentratiqn of 0.5µg. (Group _III)
allowed 16 out of. 20 PIEs to ·.progress· for _a so·% viability
and a 0.25µg.concentration of 17-B-estradiol (Group IV)
allowed 15 of 20 to progress for 75% viability.

These

two were not fo·und to be significant from the control.
No significance was visible between Groups II, III, and
IV, the varying concentrations of 17-B-estradiol.
Treatment Groups V (Jµg tamoxifen), VI (2µg
tamoxifen), VII (lµg tamoxifen), and VIII (3µg
nafoxidine) .all showed a significant (p<O. 05) decrease in
progression :to tp.e·morula stage when compared to the
control (Group I), but no significance to ·each other .
(Table 14).

These declines from a progression rate of

85% for the control (Group I). to 25% (Group V), 20%
(Group VI), 25% Group VII), and 35% (Group VIII)
demonstrate an inhibition by the anti-estrogenic
compounds, and support the suggestion that tamoxifen and
nafoxidine are potent inhibitors at the a-cell level of

_Table 13.

Group

Ipteraction · of 17-B-estra.diol on the progression of a-cell mouse
preimplantation embryos in vitro culture for .·s hours.
concentration of
Drug/Vehicle per ml

Total No. of
Embryos
· Cultured

Total No.
Advancing to
morula stage

% of a-cell Embryos·

20

16

80

16

80

Advancing after 8
hours Culture

II

17-B-Estradiol (1µg)

III

17-B-Estradiol
(0.. 5µg)

IV

17-B-Estradiol
(0.25µg)

20

15

75

I

Ethanol-Saline
Control (50µ1)

20

17

85

....-.J

Table 14.

Group

Interaction of antiestrogenic compounds on the progression of a-cell
mouse preimplantation embryos in.vitro culture for 8 hours.
Concentration of
Drug/Vehicle per ml

V

Ta.moxifen (3µg)

VI

VII

VIII

I

Total-No. of.·.
Total No.
·;. Embryos ·
Advancing to
Cultured.
morula stage

-.

% of a-cell Embryos
Advancing after 8
hours culture

20

25

Tamoxifen (2µg)

20

20

Tamoxifen (.lµg)

"20

25

20

35

Nafoxidine· (3µg)

Ethanol-Saline
20
Control (50µ1)
•significant at p < 0.05 from control.Group I

17

85

.
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development.
Incubation of PIEs in the presence of progesterone
produced the data shown in table 15.

Progesterone

concentrations of lµg (Group IX), 0.5µg (Group X), and
0.25µg (Group XI) allowed 75%, 80%, and 70%' of the a-cell
PIEs to progress, respectively.

All of these values· were

determined not to be significant from the control, Group
.I.

Neither were they found to be significant from one

another.
Upon-incubation of 8-cell PIEs in the presence of
17-B-estradioLand varying concentrat'ions.of tamoxifen
(_3µg,- :2µg, and lµg) in Groups XII, XIII, and XIV, it was
found that PIE progression is significantly (p<0.05)
decreased compared to the .controls o{ Group I and II
(Table 16) .:

These values of 35.% · for Group XII, 30% for

Group XIII, and 30% for Group XIV suggest that tamoxifen
is a potent anti-estrogenic compound in the a-cell PIE.
Culture of 3µg nafoxidine in the presence of 17-Bestradiol (Treatment Group XV) also demonstrated a
significant (p<0.05) decrease in PIE progression to 45%
from 80% allowed by the presence of lµg 17-B-estradiol in
Group II.

This suggests nafoxidine also has anti-

estrogenic effects like tamoxifen.

·culture Group XVI

(lµg progesterone and lµg of 17-B-estradiol) demonstrated
no significant.difference in progression when compared to

Table 15.

Group

Interaction of progesterone on the progression of 8-cell mouse
preimplantation·embryos in vitro culture for 8 hours.
Concentration of
Drug/Vehi~le per ml

Total No. of
Embryos
Cultured

Total No.
Advancing to
morula stage

% of 8-cell Embryos
Advancing after 8
hours Culture

IX

Progesterone (lµg)

20

15.

75

X

Progesterone (0.5µg)

20

16

80

XI

Progesterone (0.25µg)

14

70

17

85

I

Ethanol-Saline
Control. (50µ1).

20

Table 16.

Group

Interaction of tamoxifen, progesterone and nafoxidine while in the
presence of 17-B-estradiol on the progression of 8-cell mouse
preimplantation embryos in vitro culture for 8 hours.
Concentration of
Drug/Vehicle per ml

Total No. of
Embryos
Cultured

Total No.
Advancing to
morula stage

% of 8-cell Embryos
Advancing after 8
hours Culture

XII

Tamoxifen (Jµg) +
17-B-Estradiol (lµg-)

20

7•,b

35

XIII

Tamoxifen (2µg) +
17-B-estradiol (lµg)

20

6a,b

30

XIV

Tamoxifen (lµg) +
17-B-estradiol (;J..µg).

20

. 6a,b

30

XV.

Nafoxidine (3µg) +
17-B-estradiol (lµg)

20

ga,b

45

XVI

Progesterone (lµg) +
17-B-estradiol (lµg)

20

15

75

Ethanol-Saline
control (50µ1)

20

17

85

16

80

I
II

17-B-Estradiol
20
control (lµg)
•significant at p < 0.05 from control Group I
hsignificant at p < o.05 from control Group II

ul

76

the controls (Groups I and II),
PIEs in Treatment Group XVIII, incubated in the
presence of lOµg aminoglutethimide, showed that 30% of
the PIEs had advanced to the morula stage.

Treatment

Group XIX (lµg aminoglutethimide) allowed 40% progression
and Group XX (O.lµg aminoglutethimide) allowed 55%
progression.

These values were found to be significantly

(p<0.05) decreased in comparison to the control group .of
the methanol-saline solution (Group XVII). (Table 17).
Therefore, the synthesis of endogenous steroids by the acell PIEs is apparently important for proper development.
The progression rate of PIEs in Treatment Group XVIII was
also found to be significantly (p<0.05) less than Group
XX but not Group XIX.

These results suggest a dose

responsive reaction of a-cell PIEs to aminoglutethimide.

Receptor Determination Data
Positive control slides of human breast cancer
tissue known to stain positively using the ER-ICA and
PgR-ICA systems were assayed;

The resulting tissue

proved to be p'ositively -~·t.ained (greater than 20% of the
. nucl_ei were of a reddish-brown color) •

The. negative

control slide·, PIEs incubated, in the presence of normal
rat IgG no~ specific for either estrogen-or progesterone·
receptors, demonstrated no visible reddish".'brown

Table 17.

Group

Interaction of aminoglutethimide on the progression of 8-cell mouse
preimplantation.embryo~_in vitro culture. for 8 hours.
Concentration of
Drug/Vehicle per ml

Total No. of
Embryos
Cultured

Total No.
Advancing to
moru·1a stage

% of 8-cell Embryos
Advancing after 8
.hours Culture

XVIII

Aminoglutethimide
(l0µg)

20

6a,b

30

XIX

Aininoglutethimide
(lµg)

20

s•

40

xx

Aminoglutethimide
(0.lµg)

20

11'

55

17

85

XVII

Methanol-Saline
20
control (50µ1)
•significant at p < 0.05. from control Group XVII
bsignificant at p < 0.05 fre>m T.reatment Group XX

-.J
-.J·
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coloration of the nuclei or the embryonic cells
themselves from any of the 2-cell, 4-cell, and 8-cell
PIEs. · Therefore, confirming·no cross-reactivity between
the rat IgG and mouse antigen •
. The ER-ICA monoclonal assay technique performed on
2-cell, 4-cell, and a-cell PIEs showed no visible
reddish-brown colored nuclei,· and the nuclei were only
st_ained _green, due to th~ counterstain.

Therefore, the

·estrogen
receptors
were not .found to be present in
;
'

detectable concentrations of

1x10-14M or greater •

.The PgR-ICA monoclonal assay technique performed on
2-cell, 4-cell, and a-cell PIES showed·no'visible
reddish-brown colored nucle.i, and the nuclei were only
stained green, due to the.counterstain.

Therefore, the

progesterone receptors were·not found to be present in
detectable concentrations of 1x10-14M or greater.
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CHAPTER IV

DISCUSSION

Steroidfl have been shown to influence RNA
P.roduction, protein synthesis, and development of
preimplantation embryos (Schultz, 1986; DeMoss, 1991).
Preliminary studies ·by DeMoss (1991) have suggested that
17-B-estradiol has no effect upon PIE protein profiles,
but shows inhibition on cell viability at the.2-ce11·
stage of development.

The observations

o(

progesterone

influences have been concentrated on the blastocyst stage
and in

a lesser amount upon a-cell PIE viability.

Low

concentrations of progesterone have not been found to
inhibit a-cell PIE development (Warner and Tollefson,
1978) and blastocyst progression (Whitten, 1965b and
1957b; Kirkpatrick, 1971).

The influence of .17-B-

estradiol and progesterone upon 2-cell, 4-cell, and acell viability is reported in this research.

Viability Considerations

Viability studies showed Whitten's Modified Medium
to be efficient for in vitro culture of 2-cell, 4-cell,
and a-cell PIEs.

During the 8 hour incubation period the

..

control groups; containing ethanol and methanol treated
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media, showed that PIE stages were successful in
advancing to the next stage of development.

This success

was an important accomplishment, especially for the 2cell stage PIE development, to be assured of no block
phenomenon as had been reported for some mouse strains
(Whitten and Biggers, 1968).

Because of the high

progression rates in the control Treatment Groups I and
XVII the ethanol and methanol respective influence upon
development was considered to be insignificant as an
experimental variable.

Two

Cell PIEs:

Two cell PIEs treated with different

co_ncentrations of estrogen _produced varying numbers of
progression rates.

As shown in Table 3 Treatment Group

II, containing lµg 17-B-estradiol, PIE advancement was
signifi_cantly lower than the advancement for the control
group, ·suggesting that 17-B-estradiol is not required for
2-cell PIE advancement and appears to have an inhibitory
effect, possibly through some· form of negative regulation
of .g~n'omic · transcription dur.ing · the late :i-cell stage.
This supports the findings of OeMoss (1991) that 17-Bestradiol inhibited 2-cell progression.

The variable

progression rates, listed in table 3, demonstrate how'17.

'

·s-estradiol influences 2-cell PIE development in a
concentration dependent manner •. This, therefore·,
suggests that 2-cell PIEs are inhibited according to
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estrogen concentrations.
Tamoxifen and nafoxidine treated 2-cell_ PIEs
progressed to the 4-cell stage similar to Group I (Table
4), demonstrating the lack of toxicity of these two
antiestr.ogens at this level of development as earlier
demonstrated by DeMoss (1991) .. Progesterone also
demonstrated a lack of toxicity when compared to Group I
(Table 5) and no inhibitory effects upon 2-cell PIE
viability were observed.
Tamoxifen and 17-B-estradiol treated 2-cell PIEs in
Groups XII, XIII, and XIV did not significantly progress
to the 4-cell stage when compared to PIEs in Group II
·(Table 6). ,These data- suggests that' tamoxifen does not
0

'

c

'

•

•

L

•

provide protection from the toxicity of 17-B-estradiol at
the _2-cell stage, · however, the treatment groups showed
significantly less progression than the cc;mtrol Group I.
Ther_e_ was no signif;icance notE!d between the ·effects of
varying concentrations of tamoxifen on 2-cell PIE
progression.

The effec:ts of nafoxidine when cultured

with 17-B-estradiol also demonstrated the same results as
Groups XII, XIII; and XIV.

This demonstrates the effects

of nafoxidine appeared similar to that of tamoxifen.
Treatment Group XVI, progesterone and 17-B-estradiol
treated PIEs, were not. found to allow a significantly
greater number of 2-cell PIEs to progress than the
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estrogen only treatment of Group II (Table 6).

This

progression was found to be significantly less than
control Group I, and suggested that progesterone did not
provide significant protection_from the inhibitory effect
of 17-.B-estradiol upon 2-cell PIE viability.
Amirtoglutethimide treated Groups XVIII, XIX, and XX
were found not to significa,ntly decrease 2-cell PIE
progression' when compar.ed to control group XVII.
Therefore, steroids, like e~trogen o~'progesterone, are
apparently not being synthesized by the- 2-cell PIE and
This

are not influencing 2.-cell PIE development.

'

supports earlier findings that 2-cell PIEs do not
synthesize steroids (Dickmann, et al., 1975).

This

further substantiates the theory that the molecules
necessary for embryonic development through the 2-cell
PIE are pre-packaged in the oocyte during maturation
(liowlett and Bolton, 1985),
Four Cell'PIEs:

•Four cell PIES treated with

estrogen produced no significant variation at any of the
tested concentrations in progression rates when compared
to the -control Group I (Table 8 l..

These data were unlike

the 17-.B-estradiol treated 2-cell PIEs·which were
significantly less than the control group.

No ·

enhancement of progression was noted in the 4-cell PIEs,
but the toxic effects of estrogen, demonstrated at the 2-
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cell level, were not observed.

This supports the

conclusion of Warner and Tollefson (1977), that
exogenously administered estrogen neither enhances nor
inhibits embryo advancement.
Tamoxifen treated 4-cell PIEs were significantly
inhibited in comparison to the control group at all·
concentrations (Table.9).

This inhibition, however, was

not found to be concentration dependent at the levels
tested.

These data support DeMoss's (1991) suggestion

that 4-cell PIEs are capable of endogenous estrogen
production that is necessary for embr·yo development.
This also suggests· there might be estrogen receptors
within the 4-cell PIEs that.are necessary for the
development of this embryonic stage and supports Howlett
and Bolton's (1985) statement that the embryonic genome
is active at the 4-cell stage.

The negative influence of

tamoxifen ~uggests a possible blockage of endogenously
produced estrogen's influence upon 4-cell ·viability.
Nafoxidine also demonstrated the same results as
tamoxifen (Table 9), also demonstrating its
antiestrogenic activity at the 4-cell stage.
Progesterone-treated 4-cell PIEs demonstrated no
significant inhibition or enhancement of viability (Table
10) •

Tam'oxifen.and 17_;8-estradiol treated 4-cell PIEs in.
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Groups XII, XIII, XIV progressed to the a-cell stage in a
significantly lower number in all cases when compared to
PIEs in both Groups I and II (Table·11).

These data

suggests that tamoxifen inhibits 4-cell PIE development
as earlier demonstrated by DeMoss's (1991) studies on
viability and protein profil~s.

There was no evidence of

tamoxifen influences in a concentration dependent manner,
supporting previous observations that tamoxifen inhibits
estrogen stimulated growth in low concentratio~s (Fuller,
1991).

The effe_cts of nafoxidine when cultu:i:;ed with 17-

B-estradiol also demonstrated the same results at the 4·cell stage as Groups XII, XIII, XIV (Table 11).

This

demonstrates that the effect of nafoxidine is similar to
that of tamoxifen.

Treatment Group XVI, progesterone and

17-B-estradiol treated PIEs, was found not to
significantly inhibit nor enhance 4-cell PIE progression
in comparison to Groups I and II (Table 11).•.
Aminoglutethimide trea~ed Gro~ps XVIII, XIX, and XX
were not found not to significantly decrease 4-cell PIE

" XVII (Table
progression when compared to'control .Group
12-).-

This suggests no steroids are synthesized to

con-t;rol 4-cell embryo develop111ent.

These data, however,

contradict the findings that tamoxifen and nafoxidine
.
inhibit 4-cell PIE development possibly by preventing
endog~nously produced estrogen from binding its
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respective receptor.

The results possibly result from

the production of small amounts of steroids sufficient
for 4-cell·PIE development prior to the addition of
aminoglutethimide.

This suggestion of low endogenous

steroid production is also supported by Kendall's (1979)
findings that there are low concentrations of 3B-HSD, an
enzyme.necessary for the biosynthesis of most steroids,
at this stage of development·.
Eight Cell PIEs:

Eight cell PIEs treated with

varying concentrations of estrogen produced no
significant variation at any of the tested concentrations
in. viability
when compared to the control, Group I {Table
. .
.

13).

These 'ciata were unlike the 17-B-estradiol treated

2-ce_ll PIEs, which were significantly decreased iri
viability, and similar to the 4-cell PIE data.

The lack

·of the toxic effects of estrogen upon s~cell PIEs ~urther
supports the understanding that exogenou·s·ly administered
estrogen neither enhances nor inhibits embryo advancement
{Warner and Tollefson, 1977);
The treatment of a-cell PIEs with tamoxifen produced
significant inhibition of PIE development: in comparison
to the control group at all concentrations {Table 14).
This inhibition, however, was not found to be
concentration dependent at the levels tested.

This

supports the suggestion that a-cell PIEs are capable of
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endogenous estrogen production which is necess·ary for
embryo development (Demoss, 1991).

These data also

suggest that there might be estrogen receptors within the
8-cell PIEs that are necessary for the development of
this embryonic stage and support the statement that the
embryonic genome is active at the 8-cell stage (Howlett
and Botton, 1985).

The negative influence of tamoxifen

suggests a blockage of possible endogenously produced·
estrogen.
' .

Nafoxidine also demonstrated the same results

as tamoxifen
(Table 14), therefore, demonstrating
that
'
. . .
.
~

its antiestrogenic activity is similar to tamoxifen•s at
the 8-cell stage.

Progesterone treated 8-cell PIEs

demonstrated no significant inhibition or enhancement of
viability (Table 15).
Treatment of 8-cell PIEs·in Groups XII, XIII, XIV
with tamoxifen and 17-B-estradiol together caused the
progression to _the morula stage to be signiticantly lower
in all cases when compared to both controls, Groups I and·
II (Table 16).

This suggests tamoxifen inhibition of 8-

cell PIE development as earlier demonstrated by DeMoss
(1991).

The effects of nafoxidine when cultured with 17-

·s-estradiol also demonstrated the same results at the 8- •
cell stage as Groups XII, XIII, XIV (Table.16) as earlier
demonstrated by Roy, et al. (19.81).

These results

suggest that both nafoxidine and tamoxifen have
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inhibitory effects at the 8-cell stage.
Progesterone and 17-B-estradiol treated PIEs,
Treatment Group XVI, demonstrated no significant
inhibition or enhancement of 8~cell PIE viability in
comparison to Groups I and II (Table 16).
Aminoglutethimide treated Groups XVIII, XIX, and xx
were found to be significantly inhibited in comparison to
the control, Group XVII (Table 17).

These data suggest

that the synthesis of endogenous steroids·by the a-cell
PIEs is required for continued development to the morula
stage and supports the theory that the embryonic genome
is_e~pressed in a-cell PIEs (Howlett and Bolton, 1985).
This also suggests the importance of endogenous steroids
upon early embryogenesis especially during the_ 8-cell
stage of development, and endogenous steroid production
occurs within a-cell PIEs as has been foun~ in 16-cell
PIEs (Dickmann, et al., 1985).

Receptor Considerations
The positive control slides for both ER~ICA and PgRICA demonstrated the procedure was working properly.

The

·negative control also demonstrated the- lack of crossreactivity by the rat IgG with mi::,use 2-cell, 4-cell, ·or
8 . . . cerl .PIEs.

The'. ER-ICA
and PgR-ICA monoclonal assays
'

.

'

.

.

failed to demonstrate the presence of _either estrogen
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receptors or progesterone receptors at greater than or
equal to 1x10-14M concentrations.

However, these results

may be inconclusive due to the zona peilucida being
present, which may act as a barrier preventing the
entrance of the antibodies and reagents into the
embryonic cells and preventing staining.

It is ~lso

possible these receptors are present in lower
concentrations, but to date no evidence has been
presented to support this.

Summary

Treatment of 2-cell PIEs with 1µg 17-S-estradiol
produced significantly lowe~ rates of progression than
both the ethanol-saline control and tamoxifen treated
groups.

In 4-cell and a-cell cultured PIEs, the control

and 17-B-estradiol treated groups yielded significantly
higher percentages of viable PIEs thari the tamoxifen
tre'ated group •... This supports. the concept that

.

embryo_genic genome initiation .begins at the late 2-cell
'

·/.

'

'

.

PIE stage (Schultz, 1986).
·The inhibitory
action of·11-s-e~tra~iol on 2-cell
,
'

PIEs demonstrates the second cleavage division to the-4cell stage is not estrogen dependent.

A decline in

cleavage inhibition was not_ed wi.th the decline of 17-Bestradiol concentration.

This suggests the inhibition of
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17-8-estradiol is concentration dependent.
Viability studies in tamoxifen and nafoxidine
supplemented groups of 2-cell, 4~ceil, and 8-cell PIEs
demonstrated no significant effects upon 2-cell viability
.and sign_ificant inhibition at the 4-cell and 8-cell
stages.

This supports the non-steroidal antiestrogenic

properties of tamoxifen reported by DeMoss (1991) and
nafoxidine (Roy, et al., 1981; Sengupta, 1982).

The

results also Sll,ggest the importance of the estrogen
receptor and its presence within the 4-cell and 8-cell
PIEs.

Further, the reduction in viability demonstrates

the suggested.production of endogenous estrogen by PIEs
(Dickmann, et al., 1976).
· Culture tests of 2-cell· .PIEs in the presence of an
anti~strogen plus 17-B-estradiol were found to
· significantly inhibit. PIE progres·sion. . PIEs, 4-cell and
a-cell, cultured in the presence of the antiestrogen plus
17-8-estradiol were fol.ind to be significantly inhibited
in comparison to the ethanol-saline control and the PIEs
cultured iri the presence of only 17-B-estradiol.

This

further demonstrated that the antiestrogenic activity of
tamoxifen and nafoxidine are similar in early PIE
devE;llopment·.

Also, the data suggest a possible

dependence of 4-cell and 8-cell PIEs upon estrogen
activation of the embryonic genome through an estrogen
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receptor since both nafoxidine and tamoxifen employ their
antiestrogenic activity by binding the estrogen receptor
specifically (Fuller, 1991) •

Estrogen receptor studies.,

however, did not indicate the presence of the receptor at
concentrations of 10 fmoles/mg of protein or higher, but
the results did not rule out t:he possibility of receptor
presence in lower.concentrations.· ~other possibility is
the aritibodies were·not delivered inti:> the cells because
of the zona pellucida acting as a barrier •.
Treatment with progesterone
4-cell,
. ' at the 2-cell,
.
and a-cell PIE stages demonstrat·ed no significant
inhibition upon development at any stage.

Progesterone

treatment in conjunction with 17-B-estradiol treatment
demonstrated no significant protection from the
inhibitory effects of 17-B-estradiol at the 2-cell, 4cell, and 8-cell stages of development.· This suggests
there is no-obvious.synergistic effect of progesterone
and estradiol and supports Warner and Tollefson's (1978.)
findings.that there is no effect of progesterone·and.
estrogen together upon RNA synthesis in PIEs.
Progesterone receptor determination studies revealed
progesterone receptors are not present in concentrations
greater than 10 fmoles within any of the 3 stages
studied.

However, these·results may have been

inconclusive due to the possibility of the zona pellucida
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acting as a barrier to the antibodies utilized.
Treatment with _a steroid synthesis blocker,
aminoglutethimide, demonstrated no significant inhibition
of PIE progression at either the 2-cell or 4-cell stage
of development.

This suggests steroid synthesis at the

2-cell and 4-cell stage as initially stated by Dickmann,
et al. (1975) is not occurring.

Steroid synthesis :inay

not be necessary for 2-cell and 4-cell PIE progression,
cir is only needed in small amounts that this experiment·
failed to eliminate.

The a-cell PIEs were significantly

inhibited by the termination of steroid synthesis.
Suggesting endogenous steroid production by a-cell PIEs
as was found in 16-cell PIEs·(Dickmann, et al., 1985).
These results suggest steroid synthesis at the a-cell
stage is crucial for development.

Aminoglutethimide was

also shown to act in a concentration dependent manner
upon a-cell PIE viability.
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CHAPTER V

CONCLUSIONS

Data generated through viability studies suggest
that exogenously administered 17-S-estradiol influences
2-cell, 4-cell, and a-cell preimplantation embryo
development.

Administration of 17-S-estradiol was

inhibitory to 2-cell PIEs but among 4-cell and a-cell
cultured PI_Es,. 17-S-estradiol · influences were equal to
the control treatments.

Treatment of 4-cell and a-cell

PIEs with supplements of both 17-S-estradiol and an
antiestrogen demonstrate PIE dependence upon estrogen for
development.

Thus, the null hypothesis that.17-S-

estradiol influences PIE development is accepted.
However, 2-cell, 4-cell, and a-cell PIE
immu~ocytochemical studies. failed'to demonstrate estrogen
receptors to be pres·ent in greater than 10 fmoles/mg of
prot·ein.

Therefore, the hypothesis, that estrogen

receptors are present within PIEs is rejected.

However,

these results were inconclusive due to the unknown
·influence of the zona pellucida upon the passage of
immunoglobins into the embryonic cells.
Progesterone viability studies show that it has no
obvious influence over PIE development.
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Immunocytochemical studies did not demonstrate
progesterone receptors to be present at greater than 10
fmoles/mg of protein.

Therefore, the riul-1 hypothesis

that progesterone influences PIE development is rejected,
and the hypothesis that·progesterone receptors are
present within PI Es was rejected.

However, these re·sul ts

were inconclusive due to the unknown influence of the
zona pellucida upon the passage of immunoglobins into the
embryonic cells.
Tamoxifen arid nafoxidine treated 2-cell PIEs both
produced results similar to the experimental control.
Both were toxic to 4-cell
and . 8-cell PIEs.
.

When 4-cell

arid. a-cell PIEs were cultured in either tamoxifen or
riafoxidine and i7-B-estradiol progression was still
inhibited,

These data demonstrate the antiestrogenic

properties of tamoxifen and nafoxidine on· 4-cell and 8cell PIEs.

Therefore, the hypothesis ·that tamoxifen and

nafoxidine both have antiestrogenic properties in mouse
PIEs is accepted.
Aminoglutethimide treated 2-cell and 4-cell PIEs
produced results similar to the experimental control,
·suggesting the lack of endogenous steroid influence on 2cell and 4-cell PIEs.

Treatment of ·a-cell PIEs with AG

indicated endogenous steroi_d dep_endence for development.
Therefore, the._ hypothesis that there is no endogenous
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steroid synthesis by the preimplantation embryos that
influence development is rejected for the a-cell PIE and
accepted for the 2-cell and 4-cell PIEs.
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